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Abstract: A comprehensive study aimed at monitoring of temporal 
variability of illicit drugs (heroin, cocaine, amphetamine, MDMA, 
methamphetamine and cannabis) and therapeutic opiate methadone in a 
large-sized European city using wastewater-based epidemiology (WBE) was 
conducted in the city of Zagreb, Croatia, during an 8-year period (2009-
2016). The study addressed the impact of different sampling schemes on 
the assessment of temporal drug consumption patterns, in particular 
multiannual consumption trends and documented the possible errors 
associated with the one-week sampling scheme. The highest drug 
consumption prevalence was determined for cannabis (from 59 ± 18 to 156 ± 
37 doses/day/1000 inhabitants 15-64 years), followed by heroin (from 11 ± 
10  to 71 ± 19 doses/day/1000 inhabitants 15-64 years), cocaine (from 8.3 
± 0.9 to 23 ± 4.0 doses/day/1000 inhabitants 15-64 years) and amphetamine 
(from 1.3 ± 0.9 to 21 ± 6.1 doses/day/1000 inhabitants 15-64 years) 
whereas the consumption of MDMA was comparatively lower (from 0.18 ± 0.08 
to 2.7 doses ± 0.7 doses/day/1000 inhabitants 15-64 years). The drug 
consumption patterns were characterized by clearly enhanced weekend and 
Christmas season consumption of stimulating drugs (cocaine, MDMA and 
amphetamine) and somewhat lower summer consumption of almost all drugs. 
Pronounced multiannual consumption trends were determined for most of the 
illicit drugs. The investigated 8-year period was characterized by a 
marked increase of the consumption of pure cocaine (1.6-fold), THC (2.7-
fold), amphetamine (16-fold) and MDMA (15-fold) and a concomitant 
decrease (2.3-fold) of the consumption of pure heroin. The heroin 
consumption decrease was associated with an increase of methadone 
consumption (1.4-fold), which can be linked to its use in the heroin 
substitution therapy. The estimated number of average methadone doses 
consumed in the city of Zagreb was in a good agreement with the 
prescription data on treated opioid addicts in Croatia. 
 
Response to Reviewers: Reviewer #1: The authors report a WBE study in 
which they monitor temporal variability in biomarkers of heroin, cocaine, 
amphetamine, MDMA, methamphetamine and cannabis and the therapeutic 
opiate methadone in the waste water of Zagreb, Croatia over an 8-year 
period (2009-2016). The study assessed the reliability of one week vs 
annual sampling strategies on estimated temporal drug consumption 
patterns, weekday variations in the use of these drugs, and trends over 
time in the use of these drugs.  
 
Their main findings were similar to those of studies in other European 
and high income countries in that:  
* the drug with the highest consumption prevalence of use was for 
cannabis, followed by heroin, cocaine and amphetamine, with MDMA use much 
lower;   
* There were enhanced weekend and holiday consumption of cocaine, 
MDMA, and amphetamine; 
* Consumptions was marginally lower in summer for almost all drugs, 
reflecting population movements;   
* Over the 8-year study period there was increases in the consumption 
of cocaine and THC and a more marked increase in use of amphetamine (16-
fold) and MDMA (15-fold). There was a large decrease in the consumption 
of heroin over the study period and an increase in the last year of 
study.  
* The decline in heroin use was associated with an increase in 
methadone consumption that was linked to its increased use as a 
substitution treatment for heroin.  
* The estimated average daily methadone dose in the city of Zagreb 
agreed well with the prescription data on the number of opioid addicts in 
Croatia enrolled in methadone treatment. 
 
The last two findings are major novelties that have not been previously 
reported so far as I am aware, namely, a decline in indicators of heroin 
use occurring as there was increased use of methadone; and showing that 
methadone consumption estimated from waste water biomarkers closely 
agreed with data on the amount of methadone dispensed.  
 
 Q: I had one minor issue: what was the justification for the "arbitrary" 
definition of a significant ratio of weekend to weekly use of a drug, 
i.e.  1 plus or minus -0.2? 
 
 
R: The criterion was selected based on the initial insight into the day-
to-day variability of various non-stimulating drugs (in particular 
morphine, codeine and methadone) in the city of Zagreb with moderate 
relative standard deviations (RSD) of average daily loads being in the 
range up to 11 to 17%, which indicated robustness of the collective 
excretion rates as an indicator of drug abuse in larger populations. 
Moreover, this criterion is well above the possible limitations posed by 
mere repeatability of the analytical method. 
 
 
 
Reviewer #2: General Comments 
 
The manuscript presents a 7-year monitoring of selected drug consumption 
patterns in the city of Zagreb. The study presents an extensive 
monitoring data and is within the scope of STOTEN. Although similar 
studies have published before, the authors have tried to give a new 
perspective to the study by comparing monitoring data for different 
sampling periods and look for specific trends. I recommend this 
manuscript for publication following some major corrections.  
 Major comments: 
* It appears that the Authors have tried to make relatively 
generalized conclusions about any "large-sized European city" using the 
example of Zagreb with limited number of drugs considered. However, 
EMCDDA reports have shown the trends of drug use is very region-dependent 
and different for each drug. I suggest the authors to be more moderate 
and corroborate their outcomes with the studies in the same region and 
cities with similar population size.  
 
R: We do not agree with this comment. As it was clearly emphasized in the 
title, one of the primary goals of the paper was testing different 
sampling strategies (sampling schemes) and estimation of the robustness 
of the applied sampling schemes to assess relatively small changes in 
consumption rates by taking into account possible sources of temporal 
variability (weekly dynamics, seasonal variability and impact of special 
events). These are important methodological issues of general character 
applicable to any large sized city. Our study did not intend to make any 
generalization regarding the drug consumption trends in other large-sized 
European cities based on the data from the city of Zagreb. We rather 
demonstrated that considering the proper sampling schemes can 
significantly improve the reliability of the trend monitoring making 
possible detection of relatively small changes. 
 
  
* Using the term "sampling strategies", especially in the title is 
misleading. In fact, the study does not consider different sampling 
strategies (e.g. flow, volume, time proportional with different sampling 
intervals) but it rather considers different "sampling periods". 
  
R: The term “sampling strategy” was systematically replaced with the term 
“sampling scheme(s)”.  
 
* The impact of in-sewer transformations was neglected in the 
manuscript. Number of studies (including previous author's studies) have 
shown that 6-AM, BE, THC-COOH are subject to transformation or formation 
in the sewer. How do the results would change if the authors consider 
such transformations? If these in-sewer processes are not included in the 
estimation of consumption rates (e.g. not through correction factors), at 
least the possible impacts should be discussed. 
 
R: The impact of possible in-sewer transformations was not taken into 
account when estimating drug consumption. A model experiments which were 
performed at 10oC and 20oC, with the wastewater from the city of Zagreb, 
indicated rather higher stability of all urinary biomarkers within the 
wastewater in-sewer residence time (<5 h) in the city of Zagreb. Our 
study (Senta et al., 2016. Sci Tot Environ, 487, 659-665), showed that 
even the most labile biomarkers such as 6-AM, BE, THC-COOH are not 
expected to be transformed more than 10% (which we accepted as a margin 
of error). Furthermore, the study was performed within the same city (the 
same sewer system). Consequently, possible in-sewer transformations is 
not expected to have a significant effect either on the determined 
weekday/workday and holiday consumption patterns or on multiannual 
consumption trends. 
 
A possible impact of in-sewer transformations is now briefly discussed in 
the revised version (Section 3.2.3.).     
 
* Devault et al. 2017 has shown that the stability of 6-AM and THC-
COOH is greatly influenced by temperature. Since this manuscript presents 
results related to March and August how does the temperature difference 
can explain the difference between the results presented in Fig. 4. 
Unfortunately the temperature is not reported in the manuscript and the 
impact is not discussed. 
 
R: The typical in-sewer temperature in the city of Zagreb in March and 
Jul/Aug periods is 12oC and 20.5oC, respectively. Our model experiments 
which were performed at 10oC and 20oC, with the wastewater from the city 
of Zagreb, indicated rather higher stability of all urinary biomarkers 
presented in Fig. 4 at both investigated temperature conditions (Senta et 
al., 2016. Sci Tot Environ, 487, 659-665). Since the in-sewer wastewater 
residence time in the city of Zagreb is relatively short (<5 h), a 
significant impact of in-sewer degradation on the results presented on 
Figure 4 is not very likely. 
 
A possible impact of in-sewer transformations is now briefly discussed in 
the revised version (Section 3.2.3.) and the reference Devault et al., 
2017 is included.   
 
* As compared to the actual outcomes, the conclusion section is 
rather short and incomplete. This can be supplemented with some details 
as outlined in the objectives (Lines 110-114) together with some 
recommendations for future monitoring campaigns.  
 
R: The suggestion has been accepted. The conclusion section has been 
modified. 
 
Detailed comments: 
Line 142-144: When was the beginning and ending sampling in each day? 
 
R: The samples were collected from 8 a.m. of the previous day to 8 a.m. 
of the sample collection day. This info was added to the manuscript 
(Section 2.3.) 
 
Line 147-149: Are there any data that presented here but published before 
e.g. Krizman et al. 2016, Senta et al. 2015 or SCORE monitoring? This 
should be clarified in the manuscript. 
 
R: The sentence: “Since the study covers a rather long time-period, some 
of the data, resulting from the sampling campaigns described above, were 
partially used in previously published studies (e.g. Krizman et al., 
2016; Ort et al., 2014b; Terzic et al., 2010; Thomas et al., 2014).” has 
been added to the manuscript. 
  
Line 153: "The total number of samples per year varied from 21 to 46". 
These numbers do not much with the "number of analyzed samples" in Table 
2 (7 to 72). Is there any difference between number of samples and number 
of analyzed samples? 
 
R: The total number of samples per year collected within the whole-year 
sampling scheme was 21-46. However, the total number of the samples 
presented in the Table 2 includes all samples collected and analyzed 
within a specified year (e.g. the number of samples collected within the 
one-week sample scheme plus the number of samples collected within the 
whole-year sample scheme, plus the number of samples collected within the 
Christmas-New Year period).  
 Line 173 - 188: This is entirely a copy-paste from Krizman et al. 2016 
(STOTEN 566-567 (2016) 454-462).  
 
R: The applied methodology for the estimation of drug abuse is the same 
as described in Krizman et al (2016). We did our best to change the 
sentences of this part of the Section 2.4. The changes are clearly marked 
in the revised version.  
 
Line 195-197: What about correction factor for heroin?  
 
R: The following text was added to the last sentence of the Section 2.4.: 
“whereas heroin consumption was calculated from 6-AM mass loads, using a 
correction factor of 86.9 (van Nuijs et al. 2011) 
 
 
Line 209: 213: This seems to belong to Materials and Methods 
 
R: This sentence was omitted from the revised version of the manuscript.  
  
Line 210: what does the age of registered drug addicts (15-64) relate to 
your wastewater data? As you keep mentioning this range of age in your 
results, how can you make sure that people with age not included in the 
range did not contribute to your collected samples? I suggest you bring a 
strong evidence or remove it from the manuscript and Fig. 6. 
 
R: We do not agree with this comment and suggestion. The epidemiological 
data (e.g. number of registered drug users are frequently normalized on 
the population of age 15-64 years. It does not mean that all users are in 
that age group. Consequently, the WBE data are frequently normalized on 
the population of age 15-64 years old and it does not mean that only the 
population of the age 15 -64 years contributed to the sample. 
  
  250-251: this is a repeated sentence (Line 156-157), suggest to remove 
 
R: Suggestion accepted. Removed. 
 
 Line 269: "higher than" instead of "higher then" 
 
R: Corrected 
 
Line 325-331: Ort et al. 2014b, only assessed the back-calculation of COC 
using BE. So the relative error of 60% was for this specific chemicals. 
Whereas in this manuscript the chemicals are completely different and the 
error varies a lot as shown in Figure 5. So this comparison and 
generalization is not entirely valid. 
 
R: We do not agree with this comment. Ort and coworkers (2014b) addressed 
the challenges of surveying wastewater drug loads of small populations 
and generalizable aspects on optimizing monitoring design by comparing 
the results obtained for cocaine biomarker mass loads (BE and COC) using 
different sampling schemes in one small city (7160 inhabitants). Fig. 5 
contains the data for BE as well. The variability for BE for both 
sampling schemes (one-week and whole-year) was lower then 20% in all 
investigated years. Therefore, we think that the performed comparison is 
appropriate. 
 
Line 340: please check with the formatting standard of the journal when 
you refer to supplementary material.  
 
R: The expression “Electronic Supplementary Material” was replaced by 
“Supplementary Material”. 
    
Line 351: "… in some other WBE studies". This is very general. In which 
regions where those studies conducted? what population size? Which 
chemicals? 
 
R: The following text was added to the revised manuscript: 
 
„In principle, the determined drug consumption patterns and rates were 
rather similar to those determined in some other Mediterranean countries, 
like Spain and Italy (Mastroianni et al., 2017; Zuccato et al., 2016), 
although some differences regarding the prevalence of individual drugs as 
well as regarding the temporal trends were observed. For example, 
cannabis and cocaine were the most prevalently consumed illicit drugs in 
Barcelona (Spain) and investigated Italian cities, whereas a heroin 
consumption was reported to be much lower (Mastroianni et al., 2017; 
Zuccato et al., 2016).“ 
 
Line 410: "… are much smaller than those for the small communities". 
Based on which comparison this conclusion is made? This statement 
requires detailed comparison. 
 
R: The sentence was slightly changed as follows:  
“The errors associated with day-to-day and intra-annual variability of BE 
(<20%) determined in the city of Zagreb (>500 000 inhabitants) study were 
much smaller from those reported for small communities (Ort et al. 
2914b), which indicated enhanced robustness of the estimates obtained for 
large sized cities.” 
    
Figures: Please define in the figure captions what do error bars mean.  
 
R: Defined. Error bars represent standard deviations. 
 
 
 
Reviewer #3: The manuscript presents the monitoring of drug consumption 
in Zagreb using wastewater-based epidemiology from 2009-2016.  
The manuscript is fairly well written and cover a range of topics. I 
think this work is of relevance for readers of Science of the Total 
Environment and only have minor comments for the authors to remedy: 
* Despite an apparently comprehensive literature search, I believe 
the authors are missing some references that could strengthen the 
introduction. A group from South Australia have been performing bimonthly 
(every two months) sampling and it would be pertinent to include this 
somewhere in the introduction to show that there are other groups who 
don't just do one-week sampling. References could be Bade et al 
Analytical and Bioanalytical Chemistry 2018, 529-542 and Tscharke et al 
Science of the Total Environment 2016, 384-391. Furthermore, Jiang et al 
(Environmental Science and Technology 2015, 792-799) also present the use 
of wastewater-based epidemiology for analyzing drug consumption during a 
festival. I encourage the authors to cite these articles within the 
introduction. 
 
R: The suggested references are included in the revised manuscript. 
  
* The authors should be consistent with nomenclature. E.g. Line 231 
(Figure 1) then all subsequent references to figures are (Fig. 2 etc.) 
The authors should stick with one. 
 
R: Corrected. 
 
* Line 277-279 is not needed. It is replicated at the beginning of 
the next section.  
 
Removed from the revised version. 
 
* Line 304: Why were Sunday and Tuesday chosen as sampling says for 
the year-long campaign? By only sampling one weekend day, the majority of 
the stimulants would be underestimated as described later in the section.  
 
R: Sunday and Tuesday were selected as representatives of weekend day and 
week-day, respectively, for practical reasons. However, we don’t think 
that we underestimated stimulants by sampling only one weekend day. 
Namely, as clearly described in our methodology we calculated 
representative average mass loads using the weight factors of 2 and 5 for 
weekend and weekday, respectively.  
 
 
* The authors should replace "bimonthly" with "fortnightly" as 
bimonthly can be confused with "every two months". 
 
R: Replaced. 
 
* Line 407: The authors state in the conclusion that whole-year 
sampling showed a clear advantage over the seven-consecutive-day sampling 
scheme. However, in line 323, the authors state that one-week sampling 
may provide a reliable base the estimate of the annual consumption if 
most classical illicit drugs. These two sentences seem contrasting. In my 
opinion, there is no clear opinion voiced by the authors in section 3.3 
as to which sampling scheme should be used. If the authors do believe 
that year-long sampling is advantageous, they should state that in 
section 3.3.  
 
 
R: We agree with the reviewer’s comment. To avoid misinterpretations, the 
sentence in the Section 3.3. was rephrased as follows: 
“Nevertheless, although some previous studies, addressing the issue of 
multiannual changes, demonstrated the applicability of one-week sampling 
scheme (Ort et al. 2014; Mastroianni et al. 2017), our data show that 
such a scheme is insufficiently reliable for the drugs exhibiting high 
day-to-day and/or intra-annual variability, even in case of larger cities 
like the city of Zagreb.” 
 
 
* Figure 6: Why was methamphetamine not included in this figure? 
 
R: Concentration of methamphetamine in most of the samples was below MQL 
and quantifiable concentrations appeared only sporadically. Therefore, 
its consumption was not included in Fig 6 which illustrates multiannual 
trends in Zagreb since, under the circumstances, no reliable trends could 
be observed  
  
  
* Figure 7: What are "stimulants" in the epidemiological figure? 
Within the manuscript, stimulants are described as the cocaine, 
methamphetamine, amphetamine and MDMA. However, cocaine is separate in 
this figure. The authors should specify precisely what these stimulants 
cover to ensure comparability with the wastewater data. 
 
R: Stimulants in the epidemiological figure include amphetamine-type 
drugs. The explanation is added to the Figure captions.  
 
 
 
 
 
Reviewer #4: The manuscript entitled, "Long-term monitoring of drug 
consumption patterns in a large-sized European city using wastewater-
based epidemiology: comparison of sampling strategies for the assessment 
of multiannual trends" provides an interesting study for estimating drugs 
consumption in a European city. The paper is relevant, well written and 
logically constructed. The paper is of general interest.  Even though the 
research is not novel as back-calculation methods have been use in many 
papers to estimate illicit drugs in untreated wastewater. I would like to 
recommend acceptance of this manuscript however there are important 
sections of data which should be explained in more detail before 
publication to ensure the results and methodologies applied are 
transparent and adequately quality assessed. 
 
Comments 
1.In my opinion the graphical abstract is not attractive. It could be 
improved.  
 
R: This comment is not very informative. It is difficult to know what the 
reviewer means by “not attractive”. However, we hope the reviewer is 
going to find the graphical abstract being more attractive in its revised 
form.  
 
2. Line 30 and 42: According to the data, a 7-year period was conducted. 
Therefore, change 8-year period to 7-year period. 
 
R: The study was performed within an 8-year period (2009-2016) but the 
data set includes data from 7 years (2009, 2011, 2012, 2013, 2014, 2015, 
2016). 
 
3. Line 39-40. Please, specify that "holiday" refers to Christmas time. 
 
R:“holiday” replaced with “the Christmas season” 
 
4. Line 106: To be consistent with the rest of the paper, replace WBA by 
WBE. 
 
R: Corrected 
 
5. Line 134. MQ = Milli-Q water, I guess 
 
R: Corrected 
 
6. Line 128. Which deuterated standards did you use? 
 
R: All analytes had their deuterated analogues. The analytical details 
are given in the analytical method (Senta et al, Analytical and 
Bioanalytical Chemistry, 405, 3255-3268).  
 
7. Sampling data is confusing. I suggest adding the exact dates for 
sampling regarding lines 150 to 157. 
 
R: The Section 2.3. is changed in the revised version.  
 
 
8. Specify the exact total number of samples you analyzed. 
 
R: A following sentence was included in the revised manuscript: “A total 
number of 282 samples with an average pH of 7.6 ± 0.2 was collected.” 
 
9. Which was the pH sample?  
 
R: A following sentence was included in the revised manuscript: “A total 
number of 282 samples with an average pH of 7.6 ± 0.2 was collected.” 
 
10. Brief information about liquid-chromatography as well as MS/MS 
conditions should be mentioned in the text 
 
R: Some additional information on HPLC and MS conditions was added. We 
think that this should suffice considering the word count limitations. 
According to the Journal instructions, the methods which are already 
published should be summarized, and indicated by a reference, which is 
done. 
 
 
11. Lines 186-189: "The population normalized daily mass loads were 
obtained by dividing the representative average mass loads with the 
number of inhabitants (in thousands) served by the investigated WWTP, 
which was based on 2011 Census data". However, data are referred to 
population 
15-64 years along the text. Please, clarify. 
 
R: Some of the published WBE data available in the literature are 
normalized to the total population (e.g. Zuccato et al. Drug Alcohol 
Depend 2016), whereas some of them are normalized to the population of 
age 15-64 years (e.g. Mastroianni et al. 2017). To facilitate the 
comparison with the literature, the drug consumption data in the Table S2 
(Supplementary Material) are expressed in 8 different units (mg/day/1000 
inh.; mg/day/1000 inh. 15-64 years; doses/day/1000 inh.; doses/day/1000 
inh. 15-64 years; g/day; kg/year; kg/year - street purity). Only the Fig. 
7 includes consumption data normalized to the population (in thousands) 
of age 15-64 years since the epidemiological data which are included in 
this figure are normalized to the population 15-64 years old. 
Both the total population number served by the WWTP and the population 
number of age 15-64 years served by the WWTP are based on 2011 Census 
data.   
 
 
12. For the back-calculation of heroin from MOR, did you take into 
account the contribution of therapeutic MOR? It should be subtracted when 
back-calculating heroin consumption 
 
R: Heroin consumption was calculated from 6-AM. Please, check the Table 
1. 
 
 
 13. Line 259-262. Is there any explanation about the increase of MOR? 
 
R: No, currently we do not know the reason.  
 
 
14. Line 262 and 378: Typing error: replace "concomittant" by 
"concomitant" 
 
R: Corrected. 
 
15. Line 269: Change then for than in sentence "Christmas holiday season 
were 2 - 3.9-fold higher then during the average weekday" 
 
R: Corrected. 
 
16. Line 287-289. I partially agree with the authors because in summer 
there is a decrease of residential population but many tourists visit the 
city. 
 
R: Even in summer, the contribution of tourists to the city population is 
negligible (<1%; official data), whereas at the peak of summer season 
(25.7-15.8.) a significant percentage of residential population 
(unfortunately, official data are not available) leave Zagreb. This 
information was included in the revised section 3.2.3. 
 
  
17. Lines 292-294. This statement should be explained in more detailed. 
 
R: The discussion in the Section 3.2.3. has been amended to address 
possible reasons for lower summer biomarker mass loads.  
 
18. Line 298: "was based" should be replace by "were based" 
 
R: Corrected. 
 
19. Line 311. There is a typing error. Replace "occasional" by 
"occasional" 
 
R: Corrected 
 
20. Line 366. Add a reference for official data on the purity of seized 
drugs in the same period 
 
R: The data on the purity of seized drugs were provided by the Office for 
Combating Narcotic Drug Abuse of the Government of the Republic of 
Croatia. This info was added to the revised manuscript. 
 
21. Please, explain how you calculated the amounts of the street-purity 
drugs (line 367-368). 
 
R: Following sentence was added to the manuscript (Section 2.4.): “The 
amounts of street-purity drugs which circulated on the illegal market in 
Zagreb were calculated from the estimated annual consumption of pure 
drugs (expressed in kg/year), which were divided by the corresponding 
drug purity presented in Table S1.” 
 
22. Conclusions: As you have not compared errors in large cities vs small 
communities, this sentence should be modified 
.  
R: This section was thoroughly modified. 
 
23. Table 1. Put a space in "Castiglioniet al" between Castiglioni and et 
 
R: Corrected. 
 
24. Table 1. Refined correction factors have been recently proposed for 
the back-calculation of the illicit drugs considered in this work. I 
suggest the authors to check the most recently published works (for 
instance, Gracia-Lor et al. 2016) 
 
R: The refined correction factors proposed by Gracia-Lor et al. (2016) 
are applied in the revised version.  
  
25. Figure 2. A legend about the meaning of the horizontal lines should 
be included. 
 
R: The following text was added to the figure caption: „Horizontal lines 
represent arbitrarily assumed weekend to workday mass load ratio of 1.0 ± 
0.2“. 
 
26. In Figure 2, 7 and S1 it is difficult to distinguish among data due 
to similar coloured bars. Kindly, use a different means for identifying 
each analyte. 
 
R: Corrected. 
 
27. References: line 479, change Horder to Hordern 
 
R: Corrected.  
 
28. Table S2. Typing error: Change "wastwater" to wastewater 
 
R: Corrected 
 
 
Reviewer #5: This manuscript presents a long-term monitoring study of 
drug consumption in Zagreb - Croatia using wastewater-based epidemiology. 
In addition to 1 week of samples per year which is common in other 
multiannual wastewater-based epidemiology studies, the authors have also 
looked at higher sampling frequencies for a couple of years and compared 
this with the results they would have otherwise got based on only 1 week 
of sampling. The authors have also looked at drug consumption during 
holiday periods. My only major concern is that the authors appear to have 
used a static population size when the study has been conducted over an 8 
year period and thus the data may not be truly population normalised and 
thus I think this needs to be addressed or at the very minimum discussed. 
My minor comment is that there are numerous grammatical errors throughout 
the text which would have been addressed from proper editing prior to 
submission. 
 
R: We do not expect that the population in Zagreb changed significantly 
over the investigated period. For example, the difference in the number 
of city inhabitants obtained by CENSUS 2001 and CENSUS 2011 was lower 
than 2%. The number of tourists visiting Zagreb never exceeds 1% of the 
total population (official data). The only period with a significant 
change in population number might be summer vacation season (25th July – 
15th August.) due to the outward migrations of residential population 
(official data not available). Therefore, the mass loads determined 
during summer might be somewhat underestimated, which was discussed in 
Section 3.2.3.   
 
Individual points:  
Abstract 
Line 30 - grammar "an 8-year" 
 
R: Corrected 
 
Line 66 - grammar "of the WBE approach" 
 
R: Corrected 
 
Line 67 - grammar "of the WBE approach" 
 
R: Corrected 
 
Introduction 
 
Line 106 - grammar and spelling "an initial WBE"  
R: Corrected 
 
Line 107 - grammar "of the other" 
 
R: Corrected 
 
Chemicals and materials 
Line 135 - grammar "purifying with an Elix-Mili-Q-system" 
 
R: Corrected 
 
Line 136 - grammar "were purchased from Waters" 
 
R: Corrected 
 
Line 138 - grammar "were purchased from Phenomenex" 
 
R: Corrected 
 
Line 139 - grammar "were purchased from Whatman" 
 
R: Corrected 
 
Wastewater sampling and analysis 
 
Lines 144 to 149 - the way this is written is unclear 
 
 R: This part of the Section 2.3. is rewritten. We hope it is clear now. 
 
Line 162 - grammar "where performance" 
 R: Corrected 
 
Lines 186 to 189 - This is a long time to normalize to a static 
population size. Did the population change over this period? What about 
for the holiday period comparison? Were population markers assessed? 
 
R: We do not expect that the population in Zagreb changed significantly 
over the investigated period. For example, the difference in the number 
of city inhabitants obtained by CENSUS 2001 and CENSUS 2011 was < 2%. The 
number of tourists visiting Zagreb never exceeds 1% of the total 
population (official data). The only period with a significant change in 
population number might be summer vacation season (25th July – 15th 
August.) due to the outward migrations of residential population 
(official data not available). Therefore, the mass loads determined 
during summer might be somewhat underestimated, which was discussed in 
Section 3.2.3.   
 
Line 197 - grammar "using the later" 
 
R: Corrected 
 
Line 213 - grammar "in the treatment" 
 
R: Corrected 
 
The impact of holiday season on drug consumption patterns 
 
Line 252 - grammar "load" 
 
R: Corrected 
 
Line 255 - grammar "seasons" 
 
R: Corrected 
 
Line 262 - grammar - remove "a" before "holiday-related" 
R: Corrected 
 
Line 264 - be consistent with "holiday season" and "holiday-season" 
 
R: Corrected 
 
 
Lines 264 to 267 - without using de facto population sizes it seems like 
these differences might not be due to higher "per capita consumption" or 
may only be increased to a lesser extent 
 
R: We do not agree with this comment. It is not likely that the data 
presented in Fig 3 can be significantly affected by the changes in 
population in the city of Zagreb. 
 
 
Line 277 - grammar "on a one-week" 
 
R: The sentence was omitted from the revised manuscript. 
 
Lines 287 to 294 - Other studies have shown numerous markers of 
population in wastewater which even without a thorough calibration for 
the investigated catchments would at least reflect relative change in 
population size. Why have the authors ignored this aspect? 
 
R: As indicated in our response above, the official data on the 
population of the city of Zagreb do not suggest any significant changes 
during the period covered by this study. 
 
 
Impact of sampling strategy on the estimation of drug consumption in 
multiannual studies 
 
Line 298 -replace "was" with "previously conducted were"  
 
R: Corrected. 
 
Line 301 - replace "the" with "an" 
 
R: Corrected. 
 
 
Multiannual trends in drug consumption patterns and comparison with 
available epidemiological data 
 
Line 379 - spelling "substitution therapy" 
 
R: Corrected. 
 
Line 395 - grammar "the outcome" 
 
R: Corrected. 
 
Line 396 - grammar "surveys" 
 
R: Corrected. 
 
Line 412 - too many uses of "moreover" 
 
R: Corrected. 
 
 
Reviewer #6: Dear Editor, 
Thank you for your invitation to review manuscript STOTEN-D-18-06314 
entitled "Long-term monitoring of drug consumption patterns in a large-
sized European city using wastewater-based epidemiology: Comparison of 
sampling strategies for the assessment of multiannual trends." 
 
Monitoring studies are useful and the topic is of interest, so I consider 
this paper is interesting to be published in STOTEN after some minor 
changes. 
General comments 
- Why do you write sometimes 7-year study (highlights, page 6, line 114) 
and sometimes 8-year period (page 2, line 30 and 42; page 18, line 355)? 
 
R: The study was performed within an 8-year period (2009-2016) but the 
data set includes data from 7 years (2009, 2011, 2012, 2013, 2014, 2015, 
2016). To be more consistent, the corrections were made in the text 
wherever needed. 
 
- Page 4, lines 62-65, 68-70: Some references are quite old. There are a 
lot of monitoring research studies on wastewater-based epidemiology in 
the last 5 years so I recommend to authors to update references. 
 
R: Some additional references are included in the revised version. 
However, the literature on WBE of illicit drugs has become rather large 
and, since this is not a review paper, there has to be some selection. 
 
- Page 6, line 106: I think you want to say 'WBE'. 
 
R: Corrected.  
 
- I suggest extending the discussion in sections 3.1 Occurrence of drug 
biomarkers in municipal wastewater of the city of Zagreb and 3.2 Drug 
consumption patterns. Please, compare your results with other European 
countries. 
 
R: In our opinion there is no need for the extensive comparison of the 
results from Zagreb with the results from other European cities in these 
2 sections. According to the Journal’s instructions, extensive citations 
and discussion of published literature should be avoided. 
 
- Table 2. Delete vertical line between Mass load and Average (first line 
of AMP data). 
 
R: Corrected. 
 
- Figure 1 and 5. Exchange decimals in commas for decimal points. 
 
R: Corrected.  
 
 
 
 
Reviewer #7: The article titled "Long-term monitoring of drug consumption 
patterns in a large-sized European city using wastewater-based 
epidemiology: Comparison of sampling strategies for the assessment of 
multiannual trends" is based on the analysis of WBE data over an eight-
year period. Their study analyses trends revealed by the longitudinal 
data and compares sampling techniques currently used in many WBE studies. 
Based on their results, the authors propose a different sampling strategy 
different from what has been currently used in many WBE studies. 
 
With more regions implementing WBE for community drug monitoring, the 
results from this study could prove significant to improving regional and 
multi-regional sampling.  I believe this study will be of interest to 
many STOTEN readers and even more the WBE scientists. I recommend the 
article for publication.  
 
I have only few comments and suggest a thorough read-through to correct 
some typos. 
 
1. Line 183-184 authors used daily flow rates for mass load 
calculation, as such I assume you have all the flow rate data. Line 290- 
292. Do the seasonal changes in population affect the WWTP flow rates?  
 R: Yes, the data on wastewater mass flow expressed in m3/day were 
obtained from the Central WWTP of the city of Zagreb. However, the sewer 
system of the city of Zagreb receives either municipal and industrial 
wastewater as well as rain water and even some stream waters. The flow 
rates are therefore more influenced by precipitations than by changes in 
population size and cannot be used as indicators of population size 
changes.     
 
  
2. Additionally, though the proposed multiannual and seasonal sampling 
techniques applied in this study were useful in providing insight on drug 
use dynamics and better drug use estimations for Zagreb. It is difficult 
without a comparison site to tell if the same sampling technique would 
apply as well or have significant impact on a different city (smaller vs 
bigger; rural vs urban) even in Croatia.  
 
R: We believe that the improvements achieved through the use the whole-
year sampling scheme described in this paper strongly suggest that, in 
spite of possible variations in weekly and seasonal dynamics, large sized 
cities provide a robust systems for multiannual monitoring of illicit 
drugs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dr. Senka Terzic 
Division of the marine and environmental research 
Bijenička cesta 54 
P.O. BOX 180 
1000 Zagreb 
Croatia 
Tel: ++ 385 1 45 60 940 
Fax: ++385 1 468 02 42 
terzic@irb.hr 
 
 
Zagreb, 30 July 2018 
 
 
Dear dr. Pico, 
 
please find enclosed the revised version of the manuscript entitled „Long-term monitoring of drug 
consumption patterns in a large-sized European city using wastewater-based epidemiology: Comparison of two 
sampling schemes for the assessment of multiannual trends”. We carefully considered all reviewers' comments 
and provided an itemized list of responses. The changes made to the manuscript are clearly marked in the 
revised version of the manuscript using the track changes option. The version of the revised manuscript with 
the accepted changes is also submitted.  We are very grateful to all 7 reviewers whose valuable comments, 
suggestions and questions helped us to improve the manuscript.  
We hope that the revised manuscript is now acceptable for the publication in the Science of the Total 
Environment. 
Please send all further correspondence to me (terzic@irb.hr). 
 
Sincerely yours, 
 
dr. Senka Terzic 
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Title Page
ANSWERS TO THE REVIEWERS 
 
Reviewer #1: The authors report a WBE study in which they monitor temporal variability in biomarkers of heroin, 
cocaine, amphetamine, MDMA, methamphetamine and cannabis and the therapeutic opiate methadone in the 
waste water of Zagreb, Croatia over an 8-year period (2009-2016). The study assessed the reliability of one week vs 
annual sampling strategies on estimated temporal drug consumption patterns, weekday variations in the use of 
these drugs, and trends over time in the use of these drugs.  
 
Their main findings were similar to those of studies in other European and high income countries in that:  
* the drug with the highest consumption prevalence of use was for cannabis, followed by heroin, cocaine 
and amphetamine, with MDMA use much lower;   
* There were enhanced weekend and holiday consumption of cocaine, MDMA, and amphetamine; 
* Consumptions was marginally lower in summer for almost all drugs, reflecting population movements;   
* Over the 8-year study period there was increases in the consumption of cocaine and THC and a more 
marked increase in use of amphetamine (16-fold) and MDMA (15-fold). There was a large decrease in the 
consumption of heroin over the study period and an increase in the last year of study.  
* The decline in heroin use was associated with an increase in methadone consumption that was linked to 
its increased use as a substitution treatment for heroin.  
* The estimated average daily methadone dose in the city of Zagreb agreed well with the prescription data 
on the number of opioid addicts in Croatia enrolled in methadone treatment. 
 
The last two findings are major novelties that have not been previously reported so far as I am aware, namely, a 
decline in indicators of heroin use occurring as there was increased use of methadone; and showing that 
methadone consumption estimated from waste water biomarkers closely agreed with data on the amount of 
methadone dispensed.  
 
 Q: I had one minor issue: what was the justification for the "arbitrary" definition of a significant ratio of weekend 
to weekly use of a drug, i.e.  1 plus or minus -0.2? 
 
 
R: The criterion was selected based on the initial insight into the day-to-day variability of various non-stimulating 
drugs (in particular morphine, codeine and methadone) in the city of Zagreb with moderate relative standard 
deviations (RSD) of average daily loads being in the range up to 11 to 17%, which indicated robustness of the 
collective excretion rates as an indicator of drug abuse in larger populations. Moreover, this criterion is well 
above the possible limitations posed by mere repeatability of the analytical method. 
 
 
 
Reviewer #2: General Comments 
 
The manuscript presents a 7-year monitoring of selected drug consumption patterns in the city of Zagreb. The 
study presents an extensive monitoring data and is within the scope of STOTEN. Although similar studies have 
published before, the authors have tried to give a new perspective to the study by comparing monitoring data for 
different sampling periods and look for specific trends. I recommend this manuscript for publication following some 
major corrections.  
 
Major comments: 
* It appears that the Authors have tried to make relatively generalized conclusions about any "large-sized 
European city" using the example of Zagreb with limited number of drugs considered. However, EMCDDA reports 
have shown the trends of drug use is very region-dependent and different for each drug. I suggest the authors to be 
more moderate and corroborate their outcomes with the studies in the same region and cities with similar 
population size.  
 
*Responses to Reviewers Comments
R: We do not agree with this comment. As it was clearly emphasized in the title, one of the primary goals of the 
paper was testing different sampling strategies (sampling schemes) and estimation of the robustness of the 
applied sampling schemes to assess relatively small changes in consumption rates by taking into account possible 
sources of temporal variability (weekly dynamics, seasonal variability and impact of special events). These are 
important methodological issues of general character applicable to any large sized city. Our study did not intend 
to make any generalization regarding the drug consumption trends in other large-sized European cities based on 
the data from the city of Zagreb. We rather demonstrated that considering the proper sampling schemes can 
significantly improve the reliability of the trend monitoring making possible detection of relatively small 
changes. 
 
  
* Using the term "sampling strategies", especially in the title is misleading. In fact, the study does not 
consider different sampling strategies (e.g. flow, volume, time proportional with different sampling intervals) but it 
rather considers different "sampling periods". 
  
R: The term “sampling strategy” was systematically replaced with the term “sampling scheme(s)”.  
 
* The impact of in-sewer transformations was neglected in the manuscript. Number of studies (including 
previous author's studies) have shown that 6-AM, BE, THC-COOH are subject to transformation or formation in the 
sewer. How do the results would change if the authors consider such transformations? If these in-sewer processes 
are not included in the estimation of consumption rates (e.g. not through correction factors), at least the possible 
impacts should be discussed. 
 
R: The impact of possible in-sewer transformations was not taken into account when estimating drug 
consumption. A model experiments which were performed at 10
o
C and 20
o
C, with the wastewater from the city 
of Zagreb, indicated rather higher stability of all urinary biomarkers within the wastewater in-sewer residence 
time (<5 h) in the city of Zagreb. Our study (Senta et al., 2016. Sci Tot Environ, 487, 659-665), showed that even 
the most labile biomarkers such as 6-AM, BE, THC-COOH are not expected to be transformed more than 10% 
(which we accepted as a margin of error). Furthermore, the study was performed within the same city (the same 
sewer system). Consequently, possible in-sewer transformations is not expected to have a significant effect 
either on the determined weekday/workday and holiday consumption patterns or on multiannual consumption 
trends. 
 
A possible impact of in-sewer transformations is now briefly discussed in the revised version (Section 3.2.3.).     
 
* Devault et al. 2017 has shown that the stability of 6-AM and THC-COOH is greatly influenced by 
temperature. Since this manuscript presents results related to March and August how does the temperature 
difference can explain the difference between the results presented in Fig. 4. Unfortunately the temperature is not 
reported in the manuscript and the impact is not discussed. 
 
R: The typical in-sewer temperature in the city of Zagreb in March and Jul/Aug periods is 12
o
C and 20.5
o
C, 
respectively. Our model experiments which were performed at 10
o
C and 20
o
C, with the wastewater from the city 
of Zagreb, indicated rather higher stability of all urinary biomarkers presented in Fig. 4 at both investigated 
temperature conditions (Senta et al., 2016. Sci Tot Environ, 487, 659-665). Since the in-sewer wastewater 
residence time in the city of Zagreb is relatively short (<5 h), a significant impact of in-sewer degradation on the 
results presented on Figure 4 is not very likely. 
 
A possible impact of in-sewer transformations is now briefly discussed in the revised version (Section 3.2.3.) and 
the reference Devault et al., 2017 is included.   
 
* As compared to the actual outcomes, the conclusion section is rather short and incomplete. This can be 
supplemented with some details as outlined in the objectives (Lines 110-114) together with some 
recommendations for future monitoring campaigns.  
 
R: The suggestion has been accepted. The conclusion section has been modified. 
 
Detailed comments: 
Line 142-144: When was the beginning and ending sampling in each day? 
 
R: The samples were collected from 8 a.m. of the previous day to 8 a.m. of the sample collection day. This info 
was added to the manuscript (Section 2.3.) 
 
Line 147-149: Are there any data that presented here but published before e.g. Krizman et al. 2016, Senta et al. 
2015 or SCORE monitoring? This should be clarified in the manuscript. 
 
R: The sentence: “Since the study covers a rather long time-period, some of the data, resulting from the sampling 
campaigns described above, were partially used in previously published studies (e.g. Krizman et al., 2016; Ort et 
al., 2014b; Terzic et al., 2010; Thomas et al., 2014).” has been added to the manuscript. 
  
Line 153: "The total number of samples per year varied from 21 to 46". These numbers do not much with the 
"number of analyzed samples" in Table 2 (7 to 72). Is there any difference between number of samples and number 
of analyzed samples? 
 
R: The total number of samples per year collected within the whole-year sampling scheme was 21-46. However, 
the total number of the samples presented in the Table 2 includes all samples collected and analyzed within a 
specified year (e.g. the number of samples collected within the one-week sample scheme plus the number of 
samples collected within the whole-year sample scheme, plus the number of samples collected within the 
Christmas-New Year period).  
 
Line 173 - 188: This is entirely a copy-paste from Krizman et al. 2016 (STOTEN 566-567 (2016) 454-462).  
 
R: The applied methodology for the estimation of drug abuse is the same as described in Krizman et al (2016). 
We did our best to change the sentences of this part of the Section 2.4. The changes are clearly marked in the 
revised version.  
 
Line 195-197: What about correction factor for heroin?  
 
R: The following text was added to the last sentence of the Section 2.4.: 
“whereas heroin consumption was calculated from 6-AM mass loads, using a correction factor of 86.9 (van Nuijs 
et al. 2011) 
 
 
Line 209: 213: This seems to belong to Materials and Methods 
 
R: This sentence was omitted from the revised version of the manuscript.  
  
Line 210: what does the age of registered drug addicts (15-64) relate to your wastewater data? As you keep 
mentioning this range of age in your results, how can you make sure that people with age not included in the range 
did not contribute to your collected samples? I suggest you bring a strong evidence or remove it from the 
manuscript and Fig. 6. 
 
R: We do not agree with this comment and suggestion. The epidemiological data (e.g. number of registered drug 
users are frequently normalized on the population of age 15-64 years. It does not mean that all users are in that 
age group. Consequently, the WBE data are frequently normalized on the population of age 15-64 years old and 
it does not mean that only the population of the age 15 -64 years contributed to the sample. 
  
  250-251: this is a repeated sentence (Line 156-157), suggest to remove 
 
R: Suggestion accepted. Removed. 
 
 Line 269: "higher than" instead of "higher then" 
 
R: Corrected 
 
Line 325-331: Ort et al. 2014b, only assessed the back-calculation of COC using BE. So the relative error of 60% was 
for this specific chemicals. Whereas in this manuscript the chemicals are completely different and the error varies a 
lot as shown in Figure 5. So this comparison and generalization is not entirely valid. 
 
R: We do not agree with this comment. Ort and coworkers (2014b) addressed the challenges of surveying 
wastewater drug loads of small populations and generalizable aspects on optimizing monitoring design by 
comparing the results obtained for cocaine biomarker mass loads (BE and COC) using different sampling schemes 
in one small city (7160 inhabitants). Fig. 5 contains the data for BE as well. The variability for BE for both 
sampling schemes (one-week and whole-year) was lower then 20% in all investigated years. Therefore, we think 
that the performed comparison is appropriate. 
 
Line 340: please check with the formatting standard of the journal when you refer to supplementary material.  
 
R: The expression “Electronic Supplementary Material” was replaced by “Supplementary Material”. 
    
Line 351: "… in some other WBE studies". This is very general. In which regions where those studies conducted? 
what population size? Which chemicals? 
 
R: The following text was added to the revised manuscript: 
 
„In principle, the determined drug consumption patterns and rates were rather similar to those determined in 
some other Mediterranean countries, like Spain and Italy (Mastroianni et al., 2017; Zuccato et al., 2016), 
although some differences regarding the prevalence of individual drugs as well as regarding the temporal trends 
were observed. For example, cannabis and cocaine were the most prevalently consumed illicit drugs in Barcelona 
(Spain) and investigated Italian cities, whereas a heroin consumption was reported to be much lower 
(Mastroianni et al., 2017; Zuccato et al., 2016).“ 
 
Line 410: "… are much smaller than those for the small communities". Based on which comparison this conclusion 
is made? This statement requires detailed comparison. 
 
R: The sentence was slightly changed as follows:  
“The errors associated with day-to-day and intra-annual variability of BE (<20%) determined in the city of Zagreb 
(>500 000 inhabitants) study were much smaller from those reported for small communities (Ort et al. 2914b), 
which indicated enhanced robustness of the estimates obtained for large sized cities.” 
    
Figures: Please define in the figure captions what do error bars mean.  
 
R: Defined. Error bars represent standard deviations. 
 
 
 
Reviewer #3: The manuscript presents the monitoring of drug consumption in Zagreb using wastewater-based 
epidemiology from 2009-2016.  
The manuscript is fairly well written and cover a range of topics. I think this work is of relevance for readers of 
Science of the Total Environment and only have minor comments for the authors to remedy: 
* Despite an apparently comprehensive literature search, I believe the authors are missing some references 
that could strengthen the introduction. A group from South Australia have been performing bimonthly (every two 
months) sampling and it would be pertinent to include this somewhere in the introduction to show that there are 
other groups who don't just do one-week sampling. References could be Bade et al Analytical and Bioanalytical 
Chemistry 2018, 529-542 and Tscharke et al Science of the Total Environment 2016, 384-391. Furthermore, Jiang et 
al (Environmental Science and Technology 2015, 792-799) also present the use of wastewater-based epidemiology 
for analyzing drug consumption during a festival. I encourage the authors to cite these articles within the 
introduction. 
 
R: The suggested references are included in the revised manuscript. 
  
* The authors should be consistent with nomenclature. E.g. Line 231 (Figure 1) then all subsequent 
references to figures are (Fig. 2 etc.) The authors should stick with one. 
 
R: Corrected. 
 
* Line 277-279 is not needed. It is replicated at the beginning of the next section.  
 
Removed from the revised version. 
 
* Line 304: Why were Sunday and Tuesday chosen as sampling says for the year-long campaign? By only 
sampling one weekend day, the majority of the stimulants would be underestimated as described later in the 
section.  
 
R: Sunday and Tuesday were selected as representatives of weekend day and week-day, respectively, for 
practical reasons. However, we don’t think that we underestimated stimulants by sampling only one weekend 
day. Namely, as clearly described in our methodology we calculated representative average mass loads using the 
weight factors of 2 and 5 for weekend and weekday, respectively.  
 
 
* The authors should replace "bimonthly" with "fortnightly" as bimonthly can be confused with "every two 
months". 
 
R: Replaced. 
 
* Line 407: The authors state in the conclusion that whole-year sampling showed a clear advantage over the 
seven-consecutive-day sampling scheme. However, in line 323, the authors state that one-week sampling may 
provide a reliable base the estimate of the annual consumption if most classical illicit drugs. These two sentences 
seem contrasting. In my opinion, there is no clear opinion voiced by the authors in section 3.3 as to which sampling 
scheme should be used. If the authors do believe that year-long sampling is advantageous, they should state that in 
section 3.3.  
 
 
R: We agree with the reviewer’s comment. To avoid misinterpretations, the sentence in the Section 3.3. was 
rephrased as follows: 
“Nevertheless, although some previous studies, addressing the issue of multiannual changes, demonstrated the 
applicability of one-week sampling scheme (Ort et al. 2014; Mastroianni et al. 2017), our data show that such a 
scheme is insufficiently reliable for the drugs exhibiting high day-to-day and/or intra-annual variability, even in 
case of larger cities like the city of Zagreb.” 
 
 
* Figure 6: Why was methamphetamine not included in this figure? 
 
R: Concentration of methamphetamine in most of the samples was below MQL and quantifiable concentrations 
appeared only sporadically. Therefore, its consumption was not included in Fig 6 which illustrates multiannual 
trends in Zagreb since, under the circumstances, no reliable trends could be observed  
  
  
* Figure 7: What are "stimulants" in the epidemiological figure? Within the manuscript, stimulants are 
described as the cocaine, methamphetamine, amphetamine and MDMA. However, cocaine is separate in this 
figure. The authors should specify precisely what these stimulants cover to ensure comparability with the 
wastewater data. 
 
R: Stimulants in the epidemiological figure include amphetamine-type drugs. The explanation is added to the 
Figure captions.  
 
 
 
 
 
Reviewer #4: The manuscript entitled, "Long-term monitoring of drug consumption patterns in a large-sized 
European city using wastewater-based epidemiology: comparison of sampling strategies for the assessment of 
multiannual trends" provides an interesting study for estimating drugs consumption in a European city. The paper 
is relevant, well written and logically constructed. The paper is of general interest.  Even though the research is not 
novel as back-calculation methods have been use in many papers to estimate illicit drugs in untreated wastewater. 
I would like to recommend acceptance of this manuscript however there are important sections of data which 
should be explained in more detail before publication to ensure the results and methodologies applied are 
transparent and adequately quality assessed. 
 
Comments 
1.In my opinion the graphical abstract is not attractive. It could be improved.  
 
R: This comment is not very informative. It is difficult to know what the reviewer means by “not attractive”. 
However, we hope the reviewer is going to find the graphical abstract being more attractive in its revised form.  
 
2. Line 30 and 42: According to the data, a 7-year period was conducted. Therefore, change 8-year period to 7-year 
period. 
 
R: The study was performed within an 8-year period (2009-2016) but the data set includes data from 7 years 
(2009, 2011, 2012, 2013, 2014, 2015, 2016). 
 
3. Line 39-40. Please, specify that "holiday" refers to Christmas time. 
 
R:“holiday” replaced with “the Christmas season” 
 
4. Line 106: To be consistent with the rest of the paper, replace WBA by WBE. 
 
R: Corrected 
 
5. Line 134. MQ = Milli-Q water, I guess 
 
R: Corrected 
 
6. Line 128. Which deuterated standards did you use? 
 
R: All analytes had their deuterated analogues. The analytical details are given in the analytical method (Senta et 
al, Analytical and Bioanalytical Chemistry, 405, 3255-3268).  
 
7. Sampling data is confusing. I suggest adding the exact dates for sampling regarding lines 150 to 157. 
 
R: The Section 2.3. is changed in the revised version.  
 
 
8. Specify the exact total number of samples you analyzed. 
 
R: A following sentence was included in the revised manuscript: “A total number of 282 samples with an average 
pH of 7.6 ± 0.2 was collected.” 
 
9. Which was the pH sample?  
 
R: A following sentence was included in the revised manuscript: “A total number of 282 samples with an average 
pH of 7.6 ± 0.2 was collected.” 
 
10. Brief information about liquid-chromatography as well as MS/MS conditions should be mentioned in the text 
 
R: Some additional information on HPLC and MS conditions was added. We think that this should suffice 
considering the word count limitations. According to the Journal instructions, the methods which are already 
published should be summarized, and indicated by a reference, which is done. 
 
 
11. Lines 186-189: "The population normalized daily mass loads were obtained by dividing the representative 
average mass loads with the number of inhabitants (in thousands) served by the investigated WWTP, which was 
based on 2011 Census data". However, data are referred to population 
15-64 years along the text. Please, clarify. 
 
R: Some of the published WBE data available in the literature are normalized to the total population (e.g. 
Zuccato et al. Drug Alcohol Depend 2016), whereas some of them are normalized to the population of age 15-64 
years (e.g. Mastroianni et al. 2017). To facilitate the comparison with the literature, the drug consumption data 
in the Table S2 (Supplementary Material) are expressed in 8 different units (mg/day/1000 inh.; mg/day/1000 inh. 
15-64 years; doses/day/1000 inh.; doses/day/1000 inh. 15-64 years; g/day; kg/year; kg/year - street purity). Only 
the Fig. 7 includes consumption data normalized to the population (in thousands) of age 15-64 years since the 
epidemiological data which are included in this figure are normalized to the population 15-64 years old. 
Both the total population number served by the WWTP and the population number of age 15-64 years served by 
the WWTP are based on 2011 Census data.   
 
 
12. For the back-calculation of heroin from MOR, did you take into account the contribution of therapeutic MOR? It 
should be subtracted when back-calculating heroin consumption 
 
R: Heroin consumption was calculated from 6-AM. Please, check the Table 1. 
 
 
 13. Line 259-262. Is there any explanation about the increase of MOR? 
 
R: No, currently we do not know the reason.  
 
 
14. Line 262 and 378: Typing error: replace "concomittant" by "concomitant" 
 
R: Corrected. 
 
15. Line 269: Change then for than in sentence "Christmas holiday season were 2 - 3.9-fold higher then during the 
average weekday" 
 
R: Corrected. 
 
16. Line 287-289. I partially agree with the authors because in summer there is a decrease of residential population 
but many tourists visit the city. 
 
R: Even in summer, the contribution of tourists to the city population is negligible (<1%; official data), whereas at 
the peak of summer season (25.7-15.8.) a significant percentage of residential population (unfortunately, official 
data are not available) leave Zagreb. This information was included in the revised section 3.2.3. 
 
  
17. Lines 292-294. This statement should be explained in more detailed. 
 
R: The discussion in the Section 3.2.3. has been amended to address possible reasons for lower summer 
biomarker mass loads.  
 
18. Line 298: "was based" should be replace by "were based" 
 
R: Corrected. 
 
19. Line 311. There is a typing error. Replace "occasional" by "occasional" 
 
R: Corrected 
 
20. Line 366. Add a reference for official data on the purity of seized drugs in the same period 
 
R: The data on the purity of seized drugs were provided by the Office for Combating Narcotic Drug Abuse of the 
Government of the Republic of Croatia. This info was added to the revised manuscript. 
 
21. Please, explain how you calculated the amounts of the street-purity drugs (line 367-368). 
 
R: Following sentence was added to the manuscript (Section 2.4.): “The amounts of street-purity drugs which 
circulated on the illegal market in Zagreb were calculated from the estimated annual consumption of pure drugs 
(expressed in kg/year), which were divided by the corresponding drug purity presented in Table S1.” 
 
22. Conclusions: As you have not compared errors in large cities vs small communities, this sentence should be 
modified 
.  
R: This section was thoroughly modified. 
 
23. Table 1. Put a space in "Castiglioniet al" between Castiglioni and et 
 
R: Corrected. 
 
24. Table 1. Refined correction factors have been recently proposed for the back-calculation of the illicit drugs 
considered in this work. I suggest the authors to check the most recently published works (for instance, Gracia-Lor 
et al. 2016) 
 
R: The refined correction factors proposed by Gracia-Lor et al. (2016) are applied in the revised version.  
  
25. Figure 2. A legend about the meaning of the horizontal lines should be included. 
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Abstract 26 
A comprehensive study aimed at monitoring of temporal variability of illicit drugs (heroin, 27 
cocaine, amphetamine, MDMA, methamphetamine and cannabis) and therapeutic opiate 28 
methadone in a large-sized European city using wastewater-based epidemiology (WBE) was 29 
conducted in the city of Zagreb, Croatia, during an 8-year period (2009-2016). The study 30 
addressed the impact of different sampling strategies schemes on the assessment of temporal 31 
drug consumption patterns, in particular multiannual consumption trends and documented the 32 
possible errors associated with the one-week sampling scheme. The highest drug consumption 33 
prevalence was determined for cannabis (from 49 59 ± 15 18 to 131 156 ± 31 37 34 
doses/day/1000 inhabitants 15-64 years), followed by heroin (from 11 ± 10  to 71 ± 19 35 
doses/day/1000 inhabitants 15-64 years), cocaine (from 8.3 ± 0.9 to 23 ± 4.0 doses/day/1000 36 
inhabitants 15-64 years) and amphetamine (from 1.6 3 ± 1.00.9 to 25 21 ± 76.2 1 37 
doses/day/1000 inhabitants 15-64 years) whereas the consumption of MDMA was 38 
comparatively lower (from 0.06 18 ± 0.03 08 to 0.92.7 doses ± 0.2 7 doses/day/1000 inhabitants 39 
15-64 years). The drug consumption patterns were characterized by clearly enhanced weekend 40 
and Christmas holiday season consumption of stimulating drugs (cocaine, MDMA, and 41 
amphetamine) and somewhat lower summer consumption of almost all drugs. Pronounced 42 
multiannual consumption trends were determined for most of the illicit drugs. The investigated 43 
8-year period was characterized by a marked increase of the consumption of pure cocaine (1.6-44 
fold), THC (2.7-fold), amphetamine (16-fold) and MDMA (15-fold) and a concomitant decrease 45 
(2.3-fold) of the consumption of pure heroin. The heroin consumption decrease was associated 46 
with an increase of methadone consumption (1.4-fold), which can be linked to its use in the 47 
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heroin substitution therapy. The estimated number of average methadone doses consumed in 48 
the city of Zagreb was in a good agreement with the prescription data on treated opioid addicts 49 
in Croatia.  50 
 51 
Keywords: illicit drugs, opioids, multiannual trends, wastewater-based epidemiology, Zagreb, 52 
LC-MS/MS 53 
54 
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1. Introduction 55 
Abuse of illicit drugs has become a major global problem with numerous negative consequences 56 
including increase in crime rate, negative impacts on public health, economic damage as well as 57 
costs of treatment of drug addicts (EMCDDA, 2009). Consequently, knowing the extent and 58 
patterns of drug abuse is very important for planning timely and effective actions to mitigate 59 
these problems. The official data about illicit drug consumption usually include the information 60 
about the amount and purity of seized drugs, number of treated drug addicts and general 61 
population survey data, whose frequency in different countries may be rather different. In 62 
recent years, wastewater-based epidemiology (WBE) has been used as a complementary 63 
approach for the estimation of drug consumption across the world (e.g. Bijlsma et al., 2016; 64 
Bones et al., 2007; Huerta-Fontela et al., 2008; Kahn et al., 2014; Kankaanpää et al., 2014;  65 
Kasprzyk-Hordern et al., 2009; Irvine et al., 2011; Lai et al., 2013a, 2016; Metcalfe et al., 2010; 66 
Postigo et al., 2010; Terzic et al., 2010; van Nuijs et al., 2009; Zuccato et al., 2008).  67 
The main advantages of the WBE approach are objectivity and suitability for near-real-time 68 
monitoring. In order to improve and expand the WBE approach, several publications addressed 69 
the problem of uncertainties associated with sample collection (Ort et al., 2010), sample 70 
stability (McCall et al., 2016; van Nuijs, 2012; Senta et al., 2014) as well as back-calculation of 71 
drug consumption (Castiglioni et al., 2013; Gracia-Lor et al., 2016; Lai et al., 2011). A number of 72 
studies have already demonstrated the potential of WBE to provide information about the 73 
spatial (Been et al., 2016; Bijlsma et al., 2016; Kankaanpää et al., 2016; Nefau et al., 2013) and 74 
temporal (Bade et al., 2018; Been et al., 2016; Lai et al., 2016; Mastroianni et al., 2017; Tscharke 75 
at al., 2016) drug consumption patterns, including large international comparative studies (Ort 76 
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et al., 2014a; Thomas et al., 2012), which showed a pronounced regional and temporal varibility 77 
of drug abuse accross the Europe. In several studies, the potential of this approach as a 78 
complementary tool to support epidemiological and seizure data (Baz-Lomba et al., 2016; Been 79 
et al., 2016; Zuccato et al., 2016) was demonstrated. The WBE approach was also successfully 80 
applied to study the differences in drug consumption patterns between the large and small 81 
cities (Krizman et al., 2016; van Nuijs et al., 2009), with a clear indication that large cities 82 
represent communities with significantly enhanced drug consumption and, consequently, are 83 
very suitable for the investigation of the drug consumption patterns. 84 
Regarding temporal variability, a significant emphasis of existing studies was on short-term 85 
consumption variability, especially regarding so-called recreational stimulating drugs. A number 86 
of WBE studies performed in different countries confirmed an enhanced consumption of 87 
stimulating illicit drugs during the weekend (e.g. Krizman et al., 2016; Terzic et al., 2010; Thomas 88 
et al., 2012), large sport events (Gerritry et al., 2011), music festivals (Bijlsma et al., 2014; Jiang 89 
et al., 2015; Lai et al., 2013b; Mackuľak et al., 2014) and the peak of tourist season in the 90 
vaccation areas (Krizman et al., 2016; Lai et al., 2013c). In contrast, only few reports addressed 91 
the issue of multiannual changes in drug consumption patterns within the selected population 92 
(e.g. Kankaanpää et al., 2016; Mastroianni et al., 2017; Ort et al., 2014a; Tscharke at al., 2016; 93 
Zuccato et al. 2016). Most of theThe published multiannual studies were based on the 94 
comparison of one-week wastewater sampling campaigns in a given time-period (Kankaanpää 95 
et al., 2016; Mastroianni et al., 2017; Ort et al., 2014a; Zuccato et al. 2016.). In such cases, 96 
possible week-to-week variability during the particular year was not taken into account, which 97 
might increase the uncertainties related to the annual consumption estimates. In order to get a 98 
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more accurate estimate, representative of average annual drug consumption, a recent study by 99 
Ort et al. (2014b) recommended the use of stratified annual sampling to minimize the errors 100 
associated with day-to-day varibility. The importance of sampling scheme for the assessment of 101 
consumption was also discussed in Humphries et al. (2016).  102 
In this study we investigated the multiannual trends in the consumption of 6 illicit drugs 103 
(cannabis, cocaine, heroin, MDMA, amphetamine, methamphetamine) and one therapeutic 104 
opioid (methadone) in the city of Zagreb in the period 2009-2016, by applying two different 105 
sampling schemes (one-week sampling scheme and a whole-year sampling scheme). The city of 106 
Zagreb is the capital and the largest Croatian city, representing almost 20% of Croatia’s 107 
population. MoreoverFurthermore, an initial WBA WBE study conducted in Zagreb (Terzic et al., 108 
2010) indicated specific drug consumption patterns which were different from those reported 109 
for most of the other European cities, in particular regarding comparatively higher prevalence of 110 
heroin consumption and lower prevalence of cocaine and amphetamine drug consumption. 111 
The specific goals of the present study included: a) long-term study of the weekday-related drug 112 
consumption patterns; b) impact of the holiday season on drug consumption patterns; c) 113 
seasonal changes in drug consumption patterns; d) testing different sampling strategies 114 
schemes for the assessment of multiannual trends; e) tracking the multiannual changes of the 115 
drug consumption over a period of 7 8 years and comparison with the available epidemiological 116 
data. 117 
 118 
2. Materials and methods 119 
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2.1. Selection of target compounds 120 
The selection of target compounds was made based on the available data on drug consumption 121 
patterns in Croatia (Glavak Tkalic et al., 2013) and in the city of Zagreb (Krizman et al., 2016; 122 
Terzic et al., 2010). Selected analytes included morphine (MOR), morphine-3-glucuronide (M3G) 123 
and 6-acetylmorphine (6-AM) as principal heroin-derived substances as well as benzoylecgonine 124 
(BE), amphetamine (AMP), methamphetamine (MAMP), 3,4-methylendioximethamphetamine 125 
(MDMA), 11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH) and 2-ethylidene-1,5-dimethyl-126 
3,3-diphenylpyrrolidine (EDDP) as principal biomarkers of cocaine, amphetamine, 127 
methamphetamine, MDMA, cannabis and methadone consumption, respectively. 128 
  129 
2.2. Chemicals and materials 130 
Standard solutions of all target analytes (1 g/L) and their deuterated analogues (0.1 g/L) were 131 
purchased from Lipomed AG (Switzerland). Mixed standard solutions of the analytes and their 132 
deuterated analogues, used as surrogate standards, were prepared in methanol (MeOH) at 133 
concentrations of 10 mg/L and 2 mg/L, respectively, and kept in the dark at −20 °C. Aqueous 134 
ammonia solution (NH3, 25%) and LC-MS grade MeOH were purchased from Merck AG 135 
(Darmstadt, Germany). Acetic acid (CH3COOH), also LC-MS grade, formic acid (HCOOH) and 136 
phosphoric acid (H3PO4) were purchased from Fluka (Switzerland). Milli-QMQ water was 137 
obtained by purifying in with an Elix-Mili-Q-system (Millipore, Bedford, USA). Oasis MCX 138 
cartridges (150 mg / 6 mL) were produced purchased by from Waters (Milford, MA, SAD) 139 
whereas Strata NH2 (200 mg / 3 mL) cartridges as well as HPLC columns used for the 140 
chromatographic separation (Synergi Polar; 4 μm, 150 mm × 3 mm, Kinetex PFP; 2.6 μm, 100 141 
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mm × 2.1 mm) were manufactured purchased by from Phenomenex (Torrance, California, USA). 142 
Glass-fiber filters (GF/C) were delivered purchased by from Whatman (USA). 143 
 144 
2.3. Wastewater sampling and analysis 145 
The 24-h composite samples (from 8 a.m. of the previous day to 8 a.m. of the sample collection 146 
day) of untreated wastewater were collected at the inlet of the central WWTP of the city of 147 
Zagreb in the period 2009-2016, except in 2010. All collected samples were time-proportional, 148 
with the sampling time interval of 15 min. A total number of 282 samples, having an average pH 149 
of 7.6 ± 0.2, was collected. Depending on the specific research goals, different sampling 150 
schemes were applied to cover both short-time and long-term variability: one-week sample 151 
scheme, a whole-year sampling-scheme and Christmas season sampling scheme. 152 
 All investigated years included at least one one-week sampling period (25 March - 2 April 2009; 153 
26 August - 3 September 2009, 9-15 March 2011, 17-24 March 2012, 6-12 March 2013, 24 July - 154 
31 August 2013, 11-18 March 2014, 17-23 March 2015, 9-15 March 2016).   155 
In addition, in 2009 and further throughout the period 2012-2016, samples were also collected 156 
over the whole year, two to four times per month, and uniformly covered all seasons (whole-157 
year sampling scheme). In principle, a whole-year sampling scheme included a collection of 158 
equal number of weekend (Sunday) and weekday (Tuesday) samples. The total number of 159 
samples collected within one whole-year sampling scheme varied from 21 to 46. Special time-160 
periods such as Christmas holiday season and major festivals were avoided within the one-week 161 
and whole-year sampling schemes. Christmas season sampling scheme included two Christmas 162 
holiday seasons in the period: 21 December 2012 – 4 January 2013 (n=15) and 20 December 163 
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2013 – 3 January 2014 (n=14). Depending on the specific research goals, different sampling 164 
strategies were applied to cover both short-time and long-term variability. All investigated years 165 
included at least one period of seven to nine consecutive days (25 March - 2 April 2009; 26 166 
August - 3 September 2009, 9-15 March 2011, 17-24 March 2012, 6-12 March 2013, 24-31 July - 167 
2013, 11-18 March 2014, 17-23 March 2015, 9-15 March 2016).   168 
In addition, in 2009 and throughout the period 2012-2016, samples were collected over the 169 
whole year, two to four times per month, and uniformly covered all seasons. The sampling 170 
scheme included collection of a weekend sample followed by collection of a subsequent 171 
weekday (Tuesday) sample. The total number of samples per year varied from 21 to 46 samples. 172 
Special time-periods such as Christmas holiday season and major festivals were avoided during 173 
the regular sampling. To investigate the impact of special events on drug consumption, samples 174 
were collected during two holiday seasons in the period: 21 December 2012 – 4 January 2013 (n 175 
= 15) and 20 December 2013 – 3 January 2014 (n = 14). 176 
The samples collected during within the one-week sampling periods scheme as well as the 177 
samples collected during the holiday periods wereand the Christmas holiday sampling scheme 178 
were frozen immediately after collection and kept frozen until analyses, whereas all other 179 
samples were processed within a few hours after collection. Since the study covers a rather long 180 
time-period, some of the data, resulting from the sampling campaigns described above, were 181 
partially used in previously published studies (e.g. Krizman et al., 2016; Ort et al., 2014b; Terzic 182 
et al., 2010; Thomas et al., 2014). 183 
The sample preparation and LC-MS/MS analysis were performed by applying already published 184 
and validated analytical method (Senta et al., 2013). The, which performance of the method was 185 
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repetitively confirmed in 7 6 international intercalibration studies performed during the period 186 
2011-2016 (van Nuijs et al., 2018). Briefly, samples of wastewater (125 mL) were spiked with 187 
surrogate standards (120 ng/L) and after equilibration filtered using GF/C filters. After filtration, 188 
samples were enriched on Oasis MCX cartridges. The basic drugs were eluted with 6 mL of 0.5% 189 
NH3 in MeOH whereas THC-COOH was eluted with methanol and additionally cleaned-up using 190 
Strata NH2 cartridges. These two fractions were analyzed separately by triple-quadrupole liquid 191 
chromatography tandem mass spectrometry (Quantum AM, Thermo Electron, USA).  192 
Chromatographic separation of basic drug biomarkers was performed using a gradient elution 193 
on Synergy 4µ POLAR-RP 80 Å column (Phenomenex, 150 x 3 mm), whereas for the analyses of 194 
THC-COOH, Kinetex 2.6 µm PFP 100 Å (Phenomenex, 100 x 2.1 mm) column was used. Eluents 195 
used for the separation of basic analytes included 0.1% acetic acid in H2O (v/v) and 0.1% acetic 196 
acid in MeOH (v/v), whereas THC-COOH analyses were performed using H2O and MeOH as 197 
eluents. THC-COOH was analyzed in negative ionization mode (NI) whereas the analyses of all 198 
other analytes were performed in positive ionization mode (PI). Identification and quantification 199 
was performed using two characteristic transitions for each analyzed compound (MRM mode). 200 
Quantitation of all analytes was performed using corresponding deuterated internal standards 201 
for all analytes. 202 
 203 
 204 
 205 
2.4. Estimation of drug consumption 206 
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The assessment of drugEstimation of drug consumption was performed as described earlier by 207 
Krizman et al. (2016), applying the methodology originally proposed by Zuccato et al. (2008). To 208 
minimize possible weekday-related differences in drug consumption patterns (e.g. Terzic et al., 209 
2010), rThe representative average mass loads (Xrp) and their corresponding standard deviations 210 
(SRP) used for the assessment of drug consumption were calculated using the as following 211 
equationss: 212 
 213 
 214 
 215 
 216 
 217 
in which where XX (workday), S (workday), X (weekend) and S (weekend) represent the average 218 
values and standard deviations of workday and weekend daily mass loads. The The 219 
concentration equal to the half of the detection limit was applied in all cases when the analyzed 220 
urinary biomarkers were not detectable. daily mass loads were calculated by multiplying the 221 
concentrations of urinary biomarkers by the corresponding daily wastewater flow. In the case 222 
when the concentrations of the individual urinary drug biomarkers were below the detection 223 
limit, the corresponding daily mass loads were estimated using the concentration equal to the 224 
half of the detection limit. The population normalized daily mass loads were obtained by 225 
dividing the representative average mass loads with the number of inhabitants (in thousands) 226 
served by the investigated WWTP, which 227 
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The number of inhabitants as well as the number of inhabitants of age 15-64 years, served by 228 
the WWTP, was based on 2011 Census data. The consumption of individual drugs expressed as 229 
the number of average doses per 1000 inhabitants was calculated by dividing the population 230 
normalized drug consumption of individual drugs, expressed as the number of doses per 1000 231 
inhabitants, was calculated using the corresponding  with the corresponding average dose size 232 
listed in  (Table 1).  233 
The amounts of street-purity drugs which circulated on the illegal market in Zagreb were 234 
calculated from the estimated annual consumption of pure drugs (expressed in kg/year), which 235 
were divided by the corresponding drug purity presented in Table S1.Annual consumption of so 236 
called street-purity illicit drugs was calculated considering the data on the average purity of the 237 
drugs seized in Croatia in investigated years (Table S1) and WBE-based estimates of pure drug 238 
consumption.   239 
Apart from some exceptionsMost of, the correction factors used in the calculation of drug 240 
consumption were taken from the paper published by Zuccato Gracia-Lor et al. et al. 241 
(20082016). The estimation of cocaine consumption was made by using the later proposed 242 
correction factor of 3.6 (Castiglioni et al., 2013), whereas heroin consumption was calculated 243 
from 6-AM mass loads, using a correction factor of 86.9 (van Nuijs et al. 2011). 244 
 245 
2.5. Statistical evaluation  246 
Statistical analysis of the data was performed using Sigma Plot 12.0 (Systat software Inc., SAD). 247 
Depending on data distribution, parametric (t-test, One-way ANOVA) and non-parametric tests 248 
(Mann-Whitney, Kruskal-Wallis test) were applied. In order to examine differences among 249 
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multiple groups, One-way ANOVA and Kruskal-Wallis tests were used (with follow-up Holm-250 
Sidak and Dunn's method post-hoc testing, respectively) while for testing the differences 251 
between two groups, t-test and Mann-Whitney test were used.  252 
 253 
3. Results and discussion 254 
3.1. Occurrence of drug biomarkers in municipal wastewater of the city of Zagreb 255 
The study was performed in a city of Zagreb, with the population size of approximately 780000 256 
inhabitants and 3.82 registered drug addicts/1000 inhabitants of age 15-64 (data for 2016, 257 
Katalinic and Huskic 2017). The analyses included selected drug biomarkers which are excreted 258 
after the consumption of 6 illegal drugs (cannabis, heroin, cocaine, amphetamine, MDMA and 259 
methamphetamine) and methadone which is primarily used in the treatment of heroin users. 260 
The analyses performed between 2009 and 2016 showed that most of the investigated drug 261 
biomarkers were rather common constituents in the wastewater of the city of Zagreb (Table 2).  262 
The most frequently detected biomarkers were MOR, BE, THC-COOH and EDDP, which were 263 
determined in all analyzed wastewater samples (n = 270-282). Very high frequency of detection 264 
was obtained also for 6-AM (98%), M3G (97%), AMP (96%) and MDMA (99%; n = 282), whereas 265 
MAMP was the least frequently detected drug biomarker (83%). Regarding abundances, the 266 
highest average annual concentrations were determined for MOR (from 74 ± 29 ng/L to 294 ± 267 
83 ng/L), BE (from 143 ± 34 ng/L to 273 ± 101 ng/L) and EDDP (from 121 ± 41 ng/L to 190 ± 67 268 
ng/L), followed by AMP (from 7.5 ± 7.5 ng/L to 109 ± 58 ng/L) and MDMA (from 6.8 ± 7.7 ng/L to 269 
92 ± 58 ng/L). The lowest concentrations were determined for MAMP (from 0.6 ± 0.6 ng/L to 1.4 270 
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± 1.8 ng/L), M3G (from 1.6 ± 2.2 ng/L to 9.9 ± 6.7 ng/L) and 6-AM (from 2.0 ± 2.4 ng/L to 12 ± 271 
4.7 ng/L). 272 
 273 
3.2. Drug consumption patterns 274 
3.2.1. Workday/weekend drug consumption patterns 275 
Possible differences in workday to weekend consumption patterns of individual drugs have 276 
been evaluated based on the ratios of weekend and workday daily mass loads of selected drug 277 
biomarkers for individual years (Fig.ure 1). It was arbitrarily assumed that a ratio significantly 278 
different from 1.0 ± 0.2 was a confirmation of some specific weekday-related consumption 279 
pattern. It should be stressed that the ratio for MOR consumption was calculated from the 280 
corresponding mass loads of the total morphine (MORtot). The MORtot mass loads were obtained 281 
by summing up the daily mass loads of MOR and M3G (taking into account the molar ratio to 282 
MOR of 1.62). 283 
Almost all ratios of the weekend and workday average daily mass load of stimulating drug 284 
biomarkers, BE (1.5 ± 0.3 to 1.7 ± 0.5), MDMA ( 2.3 ± 0.5 to 4.3 ± 3.6 ) and AMP (1.0 ± 1.0 to 2.2 285 
± 1.3), were significantly (t-test) different from 1.0 ± 0.2. By contrast, most of the ratios for 286 
MORtot (0.95 ± 0.4 to 1.1 ± 0.3), 6-AM (0.6 ± 0.8 to 1.2 ± 0.3), THC-COOH (0.9 ± 0.4 to 1.2 ± 0.4) 287 
and EDDP (0.9 ± 0.3 to 1.1 ± 0.3) indicated a rather uniform consumption of heroin, cannabis 288 
and methadone throughout the week. The observed weekend-related drug consumption 289 
patterns of stimulating drugs (MDMA, cocaine and AMP) documented in this study not only fully 290 
support the results obtained in a number of previous studies based on 7 consecutive days 291 
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sampling scheme (e.g. Krizman et al., 2015; Ort et al., 2014a; Terzic et al., 2010; Thomas et al 292 
2012), but also confirm the robustness of the applied whole-year sampling scheme to 293 
demonstrate the importance of weekday-weekend dynamics at long-term time scales. 294 
 295 
3.2.2. The impact of holiday season on drug consumption patterns  296 
The impact of holiday season on drug consumption patterns was investigated in two selected 297 
15-days periods (21 December 2012 – 4 January 2013 and 20 December 2013 - 03 January 298 
2014). The results of this research dealing with the impact of holiday season on drug 299 
consumption patterns are presented in Fig. 2 , Fig. S1  and Fig. 3. In both periods, the 1st of 300 
January (New Year) was characterized by a significantly enhanced daily mass loads of BE (224 301 
g/day and 197 g/day), MDMA (62 g/day and 67 g/day) and AMP (42 g/day and 60 g/day), which 302 
confirmed an increased consumption of all major stimulating drugs in holiday seasons (Fig. 2). 303 
By contrast, the 25th of December (Christmas) was associated with an enhanced excretion of BE 304 
(166 g/day and 130 g/day) whereas the Christmas consumption of most amphetamine-type 305 
drugs (AMP and MDMA) was not clearly elevated. These results probably reflect the life-style 306 
differences of cocaine and amphetamine-type drug consumers within the investigated 307 
population. In both holiday season periods, a steady increase of MOR excretion towards 308 
Christmas was also observed. However this increase was not associated with the concomittant 309 
increase of 6-AM and therefore cannot be unequivocaly related to the enhanced consumption 310 
of heroin. Furthermore, unlike for stimulating drugs, a holiday-related consumption patterns 311 
could not be established for the remaining investigated drugs, such as cannabis and EDDP (Fig. 312 
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S1). The comparison of the average mass loads during the two holiday -season periods with the 313 
average weekend and workday mass loads in the corresponding years (Fig. 3) confirmed a 314 
significantly higher consumption (p < 0.05) of stimulating drugs (BE, MDMA, AMP) during the 315 
weekend (n = 19-24) and holiday -season period (n = 14-15) as compared to workday periods (n 316 
= 19-22). The average mass loads of stimulating drugs during Christmas holiday season were 2 – 317 
3.9-fold higher then than during the average weekday and 1.2 – 1.9-fold higher than during the 318 
average weekend of the corresponding year. This is in a good agreement with previous studies 319 
which indicated the enhanced consumption of stimulating drugs during the holidays, festivals, 320 
tourist seasons etc. (e.g. Krizman et al., 2016; Lai et al., 2013a; Lai et al. 2013b, van Nuijs et al., 321 
2009) and underlines the ability of the applied WBE approach to address the problem of relative 322 
contributions of special events to the overal drug consumption in a particular yearly period.  323 
 324 
3.2.3. The seasonal differences in drug consumption patterns 325 
The most frequently used sampling strategy in WBE studies is based on one-week sampling 326 
scheme which includes collection of wastewater samples over a period of 7 consecutive days 327 
(e.g. Ort et al., 2014a; Thomas et al., 2012; Zuccato et al., 2016). In this study, we compared the 328 
average daily mass loads determined in the city of Zagreb in 2 different one-week periods, early 329 
spring and summer, in 2009 and 2013. The results of this comparison are presented in Fig. 4. In 330 
both investigated years, the average summer mass loads of most of the investigated drug 331 
biomarkers were lower than those determined in early spring (Fig. 4). However the observed 332 
differences were statisticaly significant (p < 0.05; Mann-Whitney test) only for drug biomarkers 333 
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which exhibit lower intra-week variability (e.g. MORtot, THC-COOH and EDDP) whereas they 334 
were not significant for the biomarkers of stimulating drugs (BE, MDMA), probably due to the 335 
comparatively higher intra-week variability. The lower average daily mass loads determined in 336 
summer are very most likely associated with a seasonal changes in population number, which in 337 
the large continental cities, like city of Zagreb, can be characterized by a 338 
pronounceddisbalanced decrease of residential population due to outward and inward 339 
population summer tourist migrations during the summer vacation season. Namely, the 340 
contribution of  tourists to the total city population is rather negligible throughout the year 341 
(<1%, data from Zagreb Tourist Board), whereas a significant percentage of residential 342 
population might be out of town during the peak of summer season. Unfortunately, this 343 
assumption cannot be confirmed since the precise the official data on therelated to the 344 
seasonal changesoutward migrations in of the city population size were not available. Another 345 
possible factor which might have caused the observed differences in spring and summer mass 346 
loads is faster in-sewer drug biomarker degradation at higher temperatures (e.g. Devault et al., 347 
2017). However, the model experiments which were performed with the wastewater from the 348 
city of Zagreb at 10oC and 20oC, indicated rather higher stability of all urinary biomarkers 349 
included in this research at the both temperature conditions (Senta et al., 2016.). Since the in-350 
sewer wastewater residence time in Zagreb is relatively short (<5 h) and a typical wastewater 351 
temperature in March and July/August is 12oC and 20.5oC, respectively, it is not very likely that 352 
the observed seasonal mass load diferences were primarily caused by faster in-sewer 353 
degradation in summer. Although the reasons for the observed seasonal differences of the 354 
average mass loads are not yet fully understood, they indicated that the total drug consumption 355 
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might be underestimated if extrapolated from the average daily mass loads determined in 356 
summer.Nevertheless, the observed seasonal differences of the average mass loads indicated 357 
that the total drug consumption might be underestimated if extrapolated from the average 358 
daily mass loads determined in summer.  359 
 360 
 361 
3.3. Impact of sampling strategy scheme on the estimation of drug consumption in 362 
multiannual studies 363 
Most of the previously conducted multiannual WBE studies was were based on relatively short 364 
one-week sampling periods (e.g. Kankaanpää et al., 2016; Mastroianni et al., 2017, Ort et al., 365 
2014a; Zuccato et al. 2016), which, due to the possible week-to-week variability of daily mass 366 
loads, may be associated with a a potential error in tracking the drug consumption on the an 367 
annual basis. In this study, a comparison was made between the representative average daily 368 
mass loads of selected drug biomarkers obtained by applying two different sampling 369 
strategiesschemes: one-week sampling scheme (March/April 2012 – 2016) and whole-year 370 
sampling scheme (Sundays and Tuesdays; sampled either bimonthlyfortnightly in 2012-2014 or 371 
monthly in 2015-2016). Based on the extended scheme of the whole-year sampling carried out 372 
in 2013 and 2014, which included bimonthlyfortnightly sampling (n = 48), it was shown that the 373 
reduction of the sample number to half (monthly sampling; n = 24) did not significantly affect 374 
the estimate of the mass loads (t-test; p < 0.05).   375 
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The representative daily mass loads of individual drug biomarkers determined by applying the 376 
one-week and the whole-year sampling scheme are presented in Fig. 5. Apart from some 377 
occassional exceptions, the application of the whole-year sampling scheme was, in principle,  378 
associated with somewhat higher day-to-day variability of daily mass loads  than the one-week 379 
sampling scheme, which is probably a result of higher intra-annual variability of drug 380 
consumption. The amphetamine-type drugs  (MAMP, AMP and MDMA) exhibited the strongest 381 
day-to-day variability within the both sampling schemes, which is most probably associated with 382 
a rather irregular consumption pattern of these drugs, characterized by enhanced weekend and 383 
holiday consumption rates. Furthermore, the one-week sampling scheme was occasionally 384 
associated with relatively high day-to-day variability of AMP and MDMA. The statistical analysis 385 
of the data exhibited a significant difference (p < 0.05) between the representative mass loads 386 
of AMP obtained by the two applied sampling strategies schemes in all investigated years. By 387 
contrast, the differences for other investigated drug biomarkers were found to be significant (p 388 
< 0.05) only occasionally. The performed comparison indicated that, in the large cities like city of 389 
Zagreb, the one-week sampling scheme may provide a rather reliable base for the estimate of 390 
the annual consumption of most of the classical illicit drugs, assuming that the sampling periods 391 
exclude special events. Previous study by Ort at al. (2014b) has shown that the variability of 392 
drug consumption in smaller communities (<10 000 inhabitants) is extremely high, requiring 393 
very high sampling frequency to achieve the proper estimate of drug consumption. It was 394 
estimated that the average annual consumption calculated from 1-week sampling was subject 395 
to approximately 60% relative error. In contrast, our study suggests that intra-annual varibilities 396 
in larger cities can be significantly smaller allowing detection of relatively small changes (20%) of 397 
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the drug consumption among different years. Nevertheless, although some previous studies, 398 
addressing the issue of multiannual changes, demonstrated the applicability of one-week 399 
sampling scheme (Mastroianni et al., 2017; Ort et al. 2014a, Zuccato et al., 2016), our data show 400 
that such a scheme is insufficiently reliable for the drugs exhibiting high day-to-day and intra-401 
annual variability, even in case of larger cities like the city of Zagreb . 402 
3.4. Multiannual trends in drug consumption patterns and comparison with available 403 
epidemiological data  404 
The back-calculations of drug consumption were made based on representative daily mass loads 405 
determined for all samples collected within each investigated year, with the exception of those 406 
collected during the Christmas-New Year holiday seasons. The consumption was calculated for 407 
heroin, cocaine, AMP, MDMA, cannabis (THC) and methadone (MTHD).  The results expressed in 408 
mg/day/1000 inhabitants of age 15-64 are presented in Fig. 6, whereas the results expressed in 409 
other units (e.g. mg/day/1000 inhabitants, doses/day/1000 inhabitants, g/day, kg/year, kg/year 410 
of street purity drug) are given in Electronic Supplementary Material (Table S2). The highest 411 
illicit drug consumption rate was determined for cannabis (from 6153 7368 ± 1835 2197 412 
mg/day/1000 inhabitants 15-64 years to 16322 19544 ± 3862 4624 mg/day/1000 inhabitants 413 
15-64 years), followed by heroin (from 107 ± 104 mg/day/1000 inhabitants 15-64 years to 712 ± 414 
193 mg/day/1000 inhabitants 15-64 years), cocaine (from 249 ± 27 mg/day/1000 inhabitants 415 
15-64 years to 699 ± 121 mg/day/1000 inhabitants 15-64 years), MDMA (from 6.017 ± 2.67.5 416 
mg/day/1000 inhabitants 15-64 years to 88 259 ± 24 69 mg/day/1000 inhabitants 15-64 years) 417 
and AMP (from 16 13 ± 10 8.8 mg/day/1000 inhabitants 15-64 years to 251 213 ± 72 61 418 
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mg/day/100 inhabitants 15-64 years). The estimated consumption rate of the therapeutic 419 
opioid methadone was in the range from 280 ± 26 mg/day/1000 inhabitants 15-64 years to 393 420 
± 61 mg/day/1000 inhabitants 15-64 years. Collectively In principle, the determined drug 421 
consumption patterns and rates were rather similar to those determined in some other 422 
Mediterranean countries, like Spain and Italy (Mastroianni et al., 2017; Zuccato et al., 2016), 423 
although some differences regarding the prevalence of individual drugs as well as regarding the 424 
temporal trends were observed. For example, cannabis and cocaine were the most prevalently 425 
consumed illicit drugs in Barcelona (Spain) and investigated Italian cities, whereas a heroin 426 
consumption was reported to be much lower (Mastroianni et al., 2017; Zuccato et al., 2016). , 427 
the determined drug consumption rates are of similar order of magnitude as in some other WBE 428 
studies (e.g. Mastroianni et al., 2017; Zuccato et al., 2016) although there were some 429 
differences regarding the prevalence of individual drugs as well as regarding temporal trends. 430 
In our study, all investigated illicit drugs, except heroin, exhibited a significant increase (p < 431 
0.05) of the consumption rates over the investigated 8-year period (Fig. 6 and 7, Table S2). In 432 
2016, the average consumption rate of pure MDMA, AMP, THC (cannabis) and cocaine, were 433 
15-fold, 16-fold, 3-fold and 2-fold higher then than in 2009, respectively. The multiannual 434 
consumption patterns of pure AMP and MDMA were characterized by a rather continuing 435 
increase of their consumption rates (Fig. 6) over the whole investigated time period, whereas 436 
the consumption of THC (cannabis) was characterized by a significant increase in 2009-2014 437 
period (p < 0.05, 3-fold increase), and rather stable consumption rate in 2014-2016 period. By 438 
contrast, the consumption rate of pure heroin dropped significantly (p < 0.05; 5-7-fold) between 439 
2009 and 2011-2012 period, and kept at significantly lower level until 2016 (p < 0.05). However, 440 
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a significant (p < 0.05) 2-3-fold increase in pure heroin consumption was recorded between 441 
2011/2012 and 2016, which indicated a gradual recovery of heroin market in that period. 442 
Interestingly, a reduction of heroin consumption in the period 2010-2012 was reported for Italy 443 
as well (Zuccato et al., 2016).  444 
 445 
Based on the estimated amounts of consumed drugs and the official data on the purity of seized 446 
drugs in the same periodprovided by the Office for Combating Narcotic Drug Abuse of the 447 
Government of the Republic of Croatia (see Table S1), we calculated the amounts of the street-448 
purity drugs which circulated on the illegal market in Zagreb in the corresponding years (Table 449 
S2). It should be stressed that the street-drug purity of investigated drugs (heroin, 450 
amphetamine, MDMA, cocaine) exhibited a pronounced temporal variability (Table S2). The 451 
amounts of the most prevalent drugs present on the illegal market in Zagreb were as follows: 452 
from 211 to 565 kg/year of heroin, from 157 to 323 kg/year of cocaine, from 52 44 to 364 309 453 
kg/year of amphetamine, from 3.514 to 43 127 kg/year of MDMA and from 19086 22853 to 454 
45089 53988 kg/year of cannabis.   455 
Consequently, the observed multiannual trends in the consumption of pure drugs are probably 456 
not impacted exclusively by the changes in drug consumption prevalence but also by the 457 
changes in the street drug purity. In this context, it is interesting to note that a significant drop 458 
in the heroin consumption rate between 2009 and 2011/2012 was associated with a 459 
concomittant decrease of heroin street-drug purity (from 21.5% to 8.4%) and an increase in the 460 
consumption of the subpstitution theraphy drug methadone (40%), which then kept a rather 461 
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stable consumption rate in the subsequent period (2013-2016). The average number of 462 
consumed methadone doses estimated in this study (e.g. 3.1 ± 0.4 doses/day/1000 inhabitants 463 
in 2015; 80 mg/dose) were in a rather good agreement with the amount of that drug prescibed 464 
in the city of Zagreb in 2015 (11.76 DDD/TSD; DDD = 25 mg; 3.7 doses/day/1000 inhabitants for 465 
the average dose of 80 mg/L) (Draganic et al., 2017), which confirmed a reliability of WBE 466 
approach for tracking the changes of the illicit drug consumption patterns.  467 
The trends in population normalized number of addicts treated due to consumption of different 468 
types of drugs did not, however, reflect the multiannual drug consumption trends determined 469 
in this study (Fig. 7), probably due to a rather long time-gap between the initial drug 470 
consumption and the involvement of the consumers in the treatment.  471 
Furthermore, the drug consumption trends which were determined in the present study were 472 
only partialy in agreement with the results of general population surveys performed in Croatia 473 
in 2011 and 2015, which indicated a significant increase only in the consumption of cannabis 474 
(2.9% last-month prevalence in 2011; 5.0% last-month prevalence in 2016) (Glavak Tkalic et al., 475 
2013; Glavak Tkalic et al., 2016), whereas the differences in the consumption prevalence of 476 
other illicit drugs were not found to be significant. Our study suggests that the outcome of 477 
national population surveys on drug consumption is not necessarily representative for larger 478 
cities. Given the fact that the city of Zagreb represents approximately 20% of the whole Croatian 479 
population, the drug consumption trends determined in this study imply the need for specific 480 
surveys focusing on larger cities. Moreover, the trends observed in the city of Zagreb might be 481 
indicative an indication of some trends developing at the national level.   482 
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 483 
5. Conclusion 484 
The seveneight-year monitoring period of drug consumption patterns in the city of Zagreb, 485 
Croatia, using wastewater-based epidemiology revealed several temporal variability patterns, 486 
including weekday-weekend dynamics, holiday season effects and multiannual trends. In 487 
agreement with the literature, the enhanced consumption of stimulating drugs was 488 
systematically observed during weekends and Christmas holiday season. In addition, a 489 
significant multiannual increase of cocaine (1.6-fold), THC (2.7-fold), amphetamine (16-fold) and 490 
MDMA (15-fold) consumption with a concomitant decrease (2.3-fold) of the consumption of 491 
heroin was observed during the investigated 8-year period (2009-2016). All these variabilities 492 
should be taken into account to get a representative estimate of the average annual 493 
consumption for comparison of different years. The whole-year sampling The whole-year 494 
sampling strategyscheme showed a clear advantage over the seven-consecutive-dayone-week 495 
sampling scheme, especially for drugs showing enhanced day-to-day and intra-annual 496 
variability. which has been recently applied to study multiannual trends. Moreover, it was 497 
shown that tThe errors associated with day-to-day and intra-annual variability of BE (<20%) for 498 
large citiesdetermined in the city of Zagreb (>500 000 inhabitants) study were  are much smaller 499 
than from those for thereported for small communities (,Ort et al. 20914b), which indicated 500 
enhanced robustness of the estimates obtained for large sized cities. Our data suggest that large 501 
sized cities can provide providing a basis for the a reliable detection of relatively small changes 502 
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in drug consumption over a multi-year period. MoreoverConsequently, t, the trends observed in 503 
the larger cities could be used as an early warning of the trends developing at the national level.   504 
 505 
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Figure captions 680 
 681 
Fig.ure 1.  Ratios of weekend and workday average mass loads of selected urinary drug 682 
biomarkers (MORtot, 6-AM, AMP, MDMA, BE, THC-COOH, EDDP) determined in the period from 683 
2009 to 2016. Error bars represent standard deviations. Horizontal lines represent arbitrarily 684 
assumed  weekend to workday mass load ratio of 1.0 ± 0.2. 685 
Fig.ure 2.  Mass loads of BE, MDMA and AMP in two different Christmas-New Year holiday 686 
periods: A) 2012/2013 and B) 2013/2014. 687 
Fig.ure 3.  Average mass loads of selected drug biomarkers determined on workdays, weekend 688 
and during two Christmas-New Year periods: A) 2012/2013 and B) 2013/2014. Error bars 689 
represent standard deviations. 690 
Fig.ure 4. Variability of average mass loads of selected urinary drug biomarkers in Zagreb during 691 
the spring and summer sampling week in A) 2009 and B) 2013. Error bars represent standard 692 
deviations. 693 
Fig.ure 5. Impact of the selected sampling strategy schemes (whole-year and one-week 694 
monitoring) on the determination of representative mass loads. Error bars represent standard 695 
deviations. 696 
Fig.ure 6. Consumption of cocaine, heroin, MDMA, amphetamine, THC and methadone in the 697 
city of Zagreb in the period 2009-2016. Error bars represent standard deviations. 698 
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Fig.ure 7. Comparison of estimated drug consumption in the city of Zagreb with available 699 
epidemiological data for Croatia in the period of 2009-2016. Stimulants in the epidemiological 700 
figure include amphetamine-type drugs. Opiates include heroin and morphine.  701 
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Abstract 26 
A comprehensive study aimed at monitoring of temporal variability of illicit drugs (heroin, 27 
cocaine, amphetamine, MDMA, methamphetamine and cannabis) and therapeutic opiate 28 
methadone in a large-sized European city using wastewater-based epidemiology (WBE) was 29 
conducted in the city of Zagreb, Croatia, during an 8-year period (2009-2016). The study 30 
addressed the impact of different sampling schemes on the assessment of temporal drug 31 
consumption patterns, in particular multiannual consumption trends and documented the 32 
possible errors associated with the one-week sampling scheme. The highest drug consumption 33 
prevalence was determined for cannabis (from 59 ± 18 to 156 ± 37 doses/day/1000 inhabitants 34 
15-64 years), followed by heroin (from 11 ± 10  to 71 ± 19 doses/day/1000 inhabitants 15-64 35 
years), cocaine (from 8.3 ± 0.9 to 23 ± 4.0 doses/day/1000 inhabitants 15-64 years) and 36 
amphetamine (from 1.3 ± 0.9 to 21 ± 6.1 doses/day/1000 inhabitants 15-64 years) whereas the 37 
consumption of MDMA was comparatively lower (from 0.18 ± 0.08 to 2.7 doses ± 0.7 38 
doses/day/1000 inhabitants 15-64 years). The drug consumption patterns were characterized by 39 
clearly enhanced weekend and Christmas season consumption of stimulating drugs (cocaine, 40 
MDMA and amphetamine) and somewhat lower summer consumption of almost all drugs. 41 
Pronounced multiannual consumption trends were determined for most of the illicit drugs. The 42 
investigated 8-year period was characterized by a marked increase of the consumption of pure 43 
cocaine (1.6-fold), THC (2.7-fold), amphetamine (16-fold) and MDMA (15-fold) and a 44 
concomitant decrease (2.3-fold) of the consumption of pure heroin. The heroin consumption 45 
decrease was associated with an increase of methadone consumption (1.4-fold), which can be 46 
linked to its use in the heroin substitution therapy. The estimated number of average 47 
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methadone doses consumed in the city of Zagreb was in a good agreement with the 48 
prescription data on treated opioid addicts in Croatia.  49 
 50 
Keywords: illicit drugs, opioids, multiannual trends, wastewater-based epidemiology, Zagreb, 51 
LC-MS/MS 52 
53 
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1. Introduction 54 
Abuse of illicit drugs has become a major global problem with numerous negative consequences 55 
including increase in crime rate, negative impacts on public health, economic damage as well as 56 
costs of treatment of drug addicts (EMCDDA, 2009). Consequently, knowing the extent and 57 
patterns of drug abuse is very important for planning timely and effective actions to mitigate 58 
these problems. The official data about illicit drug consumption usually include the information 59 
about the amount and purity of seized drugs, number of treated drug addicts and general 60 
population survey data, whose frequency in different countries may be rather different. In 61 
recent years, wastewater-based epidemiology (WBE) has been used as a complementary 62 
approach for the estimation of drug consumption across the world (e.g. Bijlsma et al., 2016; 63 
Bones et al., 2007; Huerta-Fontela et al., 2008; Kahn et al., 2014; Kankaanpää et al., 2014;  64 
Kasprzyk-Hordern et al., 2009; Irvine et al., 2011; Lai et al., 2013a, 2016; Metcalfe et al., 2010; 65 
Postigo et al., 2010; Terzic et al., 2010; van Nuijs et al., 2009; Zuccato et al., 2008).  66 
The main advantages of the WBE approach are objectivity and suitability for near-real-time 67 
monitoring. In order to improve and expand the WBE approach, several publications addressed 68 
the problem of uncertainties associated with sample collection (Ort et al., 2010), sample 69 
stability (McCall et al., 2016; van Nuijs, 2012; Senta et al., 2014) as well as back-calculation of 70 
drug consumption (Castiglioni et al., 2013; Gracia-Lor et al., 2016; Lai et al., 2011). A number of 71 
studies have already demonstrated the potential of WBE to provide information about the 72 
spatial (Been et al., 2016; Bijlsma et al., 2016; Kankaanpää et al., 2016; Nefau et al., 2013) and 73 
temporal (Bade et al., 2018; Been et al., 2016; Lai et al., 2016; Mastroianni et al., 2017; Tscharke 74 
at al., 2016) drug consumption patterns, including large international comparative studies (Ort 75 
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et al., 2014a; Thomas et al., 2012), which showed a pronounced regional and temporal varibility 76 
of drug abuse accross the Europe. In several studies, the potential of this approach as a 77 
complementary tool to support epidemiological and seizure data (Baz-Lomba et al., 2016; Been 78 
et al., 2016; Zuccato et al., 2016) was demonstrated. The WBE approach was also successfully 79 
applied to study the differences in drug consumption patterns between the large and small 80 
cities (Krizman et al., 2016; van Nuijs et al., 2009), with a clear indication that large cities 81 
represent communities with significantly enhanced drug consumption and, consequently, are 82 
very suitable for the investigation of the drug consumption patterns. 83 
Regarding temporal variability, a significant emphasis of existing studies was on short-term 84 
consumption variability, especially regarding so-called recreational stimulating drugs. A number 85 
of WBE studies performed in different countries confirmed an enhanced consumption of 86 
stimulating illicit drugs during the weekend (e.g. Krizman et al., 2016; Terzic et al., 2010; Thomas 87 
et al., 2012), large sport events (Gerritry et al., 2011), music festivals (Bijlsma et al., 2014; Jiang 88 
et al., 2015; Lai et al., 2013b; Mackuľak et al., 2014) and the peak of tourist season in the 89 
vaccation areas (Krizman et al., 2016; Lai et al., 2013c). In contrast, only few reports addressed 90 
the issue of multiannual changes in drug consumption patterns within the selected population 91 
(e.g. Kankaanpää et al., 2016; Mastroianni et al., 2017; Ort et al., 2014a; Tscharke at al., 2016; 92 
Zuccato et al. 2016). Most of the published multiannual studies were based on the comparison 93 
of one-week wastewater sampling campaigns in a given time-period (Kankaanpää et al., 2016; 94 
Mastroianni et al., 2017; Ort et al., 2014a; Zuccato et al. 2016.). In such cases, possible week-to-95 
week variability during the particular year was not taken into account, which might increase the 96 
uncertainties related to the annual consumption estimates. In order to get a more accurate 97 
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estimate, representative of average annual drug consumption, a recent study by Ort et al. 98 
(2014b) recommended the use of stratified annual sampling to minimize the errors associated 99 
with day-to-day varibility. The importance of sampling scheme for the assessment of 100 
consumption was also discussed in Humphries et al. (2016).  101 
In this study we investigated the multiannual trends in the consumption of 6 illicit drugs 102 
(cannabis, cocaine, heroin, MDMA, amphetamine, methamphetamine) and one therapeutic 103 
opioid (methadone) in the city of Zagreb in the period 2009-2016, by applying two different 104 
sampling schemes (one-week sampling scheme and a whole-year sampling scheme). The city of 105 
Zagreb is the capital and the largest Croatian city, representing almost 20% of Croatia’s 106 
population. Furthermore, an initial WBE study conducted in Zagreb (Terzic et al., 2010) indicated 107 
specific drug consumption patterns which were different from those reported for most of the 108 
other European cities, in particular regarding comparatively higher prevalence of heroin 109 
consumption and lower prevalence of cocaine and amphetamine drug consumption. 110 
The specific goals of the present study included: a) long-term study of the weekday-related drug 111 
consumption patterns; b) impact of the holiday season on drug consumption patterns; c) 112 
seasonal changes in drug consumption patterns; d) testing different sampling schemes for the 113 
assessment of multiannual trends; e) tracking the multiannual changes of the drug consumption 114 
over a period of 8 years and comparison with the available epidemiological data. 115 
 116 
2. Materials and methods 117 
2.1. Selection of target compounds 118 
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The selection of target compounds was based on the available data on drug consumption 119 
patterns in Croatia (Glavak Tkalic et al., 2013) and in the city of Zagreb (Krizman et al., 2016; 120 
Terzic et al., 2010). Selected analytes included morphine (MOR), morphine-3-glucuronide (M3G) 121 
and 6-acetylmorphine (6-AM) as principal heroin-derived substances as well as benzoylecgonine 122 
(BE), amphetamine (AMP), methamphetamine (MAMP), 3,4-methylendioximethamphetamine 123 
(MDMA), 11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH) and 2-ethylidene-1,5-dimethyl-124 
3,3-diphenylpyrrolidine (EDDP) as principal biomarkers of cocaine, amphetamine, 125 
methamphetamine, MDMA, cannabis and methadone consumption, respectively. 126 
  127 
2.2. Chemicals and materials 128 
Standard solutions of all target analytes (1 g/L) and their deuterated analogues (0.1 g/L) were 129 
purchased from Lipomed AG (Switzerland). Mixed standard solutions of the analytes and their 130 
deuterated analogues, used as surrogate standards, were prepared in methanol (MeOH) at 131 
concentrations of 10 mg/L and 2 mg/L, respectively, and kept in the dark at −20 °C. Aqueous 132 
ammonia solution (NH3, 25%) and LC-MS grade MeOH were purchased from Merck AG 133 
(Darmstadt, Germany). Acetic acid (CH3COOH), also LC-MS grade, formic acid (HCOOH) and 134 
phosphoric acid (H3PO4) were purchased from Fluka (Switzerland). Milli-Q water was obtained 135 
by purifying with an Elix-Mili-Q-system (Millipore, Bedford, USA). Oasis MCX cartridges (150 mg 136 
/ 6 mL) were purchased from Waters (Milford, MA, SAD) whereas Strata NH2 (200 mg / 3 mL) 137 
cartridges as well as HPLC columns used for the chromatographic separation (Synergi Polar; 4 138 
μm, 150 mm × 3 mm, Kinetex PFP; 2.6 μm, 100 mm × 2.1 mm) were purchased from 139 
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Phenomenex (Torrance, California, USA). Glass-fiber filters (GF/C) were purchased from 140 
Whatman (USA). 141 
 142 
2.3. Wastewater sampling and analysis 143 
The 24-h composite samples (from 8 a.m. of the previous day to 8 a.m. of the sample collection 144 
day) of untreated wastewater were collected at the inlet of the central WWTP of the city of 145 
Zagreb in the period 2009-2016, except in 2010. All collected samples were time-proportional, 146 
with the sampling time interval of 15 min. A total number of 282 samples, having an average pH 147 
of 7.6 ± 0.2, was collected. Depending on the specific research goals, different sampling 148 
schemes were applied to cover both short-time and long-term variability: one-week sample 149 
scheme, a whole-year sampling-scheme and Christmas season sampling scheme. 150 
 All investigated years included at least one one-week sampling period (25 March - 2 April 2009; 151 
26 August - 3 September 2009, 9-15 March 2011, 17-24 March 2012, 6-12 March 2013, 24 July - 152 
31 August 2013, 11-18 March 2014, 17-23 March 2015, 9-15 March 2016).   153 
In addition, in 2009 and further throughout the period 2012-2016, samples were also collected 154 
over the whole year, two to four times per month, and uniformly covered all seasons (whole-155 
year sampling scheme). In principle, a whole-year sampling scheme included a collection of 156 
equal number of weekend (Sunday) and weekday (Tuesday) samples. The total number of 157 
samples collected within one whole-year sampling scheme varied from 21 to 46. Special time-158 
periods such as Christmas holiday season and major festivals were avoided within the one-week 159 
and whole-year sampling schemes. Christmas season sampling scheme included two Christmas 160 
holiday seasons in the period: 21 December 2012 – 4 January 2013 (n=15) and 20 December 161 
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2013 – 3 January 2014 (n=14). The samples collected within the one-week sampling scheme and 162 
the Christmas holiday sampling scheme were frozen immediately after collection and kept 163 
frozen until analyses, whereas all other samples were processed within a few hours after 164 
collection. Since the study covers a rather long time-period, some of the data, resulting from the 165 
sampling campaigns described above, were partially used in previously published studies (e.g. 166 
Krizman et al., 2016; Ort et al., 2014b; Terzic et al., 2010; Thomas et al., 2014). 167 
The sample preparation and LC-MS/MS analysis were performed by applying already published 168 
and validated analytical method (Senta et al., 2013). The performance of the method was 169 
repetitively confirmed in 6 international intercalibration studies performed during the period 170 
2011-2016 (van Nuijs et al., 2018). Briefly, samples of wastewater (125 mL) were spiked with 171 
surrogate standards (120 ng/L) and after equilibration filtered using GF/C filters. After filtration, 172 
samples were enriched on Oasis MCX cartridges. The basic drugs were eluted with 6 mL of 0.5% 173 
NH3 in MeOH whereas THC-COOH was eluted with methanol and additionally cleaned-up using 174 
Strata NH2 cartridges. These two fractions were analyzed separately by triple-quadrupole liquid 175 
chromatography tandem mass spectrometry (Quantum AM, Thermo Electron, USA).  176 
Chromatographic separation of basic drug biomarkers was performed using a gradient elution 177 
on Synergy 4µ POLAR-RP 80 Å column (Phenomenex, 150 x 3 mm), whereas for the analyses of 178 
THC-COOH, Kinetex 2.6 µm PFP 100 Å (Phenomenex, 100 x 2.1 mm) column was used. Eluents 179 
used for the separation of basic analytes included 0.1% acetic acid in H2O (v/v) and 0.1% acetic 180 
acid in MeOH (v/v), whereas THC-COOH analyses were performed using H2O and MeOH as 181 
eluents. THC-COOH was analyzed in negative ionization mode (NI) whereas the analyses of all 182 
other analytes were performed in positive ionization mode (PI). Identification and quantification 183 
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was performed using two characteristic transitions for each analyzed compound (MRM mode). 184 
Quantitation of all analytes was performed using corresponding deuterated internal standards 185 
for all analytes. 186 
 187 
2.4. Estimation of drug consumption 188 
Estimation of drug consumption was performed as described earlier by Krizman et al. (2016), 189 
applying the methodology originally proposed by Zuccato et al. (2008). The representative 190 
average mass loads (Xrp) and their corresponding standard deviations (SRP) used for the 191 
assessment of drug consumption were calculated using the following equations: 192 
 193 
 194 
 195 
 196 
 197 
in which  X (workday), S (workday), X (weekend) and S (weekend) represent the average values 198 
and standard deviations of workday and weekend daily mass loads. The concentration equal to 199 
the half of the detection limit was applied in all cases when the analyzed urinary biomarkers 200 
were not detectable.  201 
The number of inhabitants as well as the number of inhabitants of age 15-64 years, served by 202 
the WWTP, was based on 2011 Census data. The normalized consumption of individual drugs, 203 
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expressed as the number of doses per 1000 inhabitants, was calculated using the corresponding 204 
average dose size listed in Table 1.  205 
The amounts of street-purity drugs which circulated on the illegal market in Zagreb were 206 
calculated from the estimated annual consumption of pure drugs (expressed in kg/year), which 207 
were divided by the corresponding drug purity presented in Table S1. 208 
Most of the correction factors used in the calculation of drug consumption were taken from the 209 
paper published by Gracia-Lor et al. (2016). The estimation of cocaine consumption was made 210 
by using the correction factor of 3.6 (Castiglioni et al., 2013), whereas heroin consumption was 211 
calculated from 6-AM mass loads, using a correction factor of 86.9 (van Nuijs et al. 2011). 212 
 213 
2.5. Statistical evaluation  214 
Statistical analysis of the data was performed using Sigma Plot 12.0 (Systat software Inc., SAD). 215 
Depending on data distribution, parametric (t-test, One-way ANOVA) and non-parametric tests 216 
(Mann-Whitney, Kruskal-Wallis test) were applied. In order to examine differences among 217 
multiple groups, One-way ANOVA and Kruskal-Wallis tests were used (with follow-up Holm-218 
Sidak and Dunn's method post-hoc testing, respectively) while for testing the differences 219 
between two groups, t-test and Mann-Whitney test were used.  220 
 221 
3. Results and discussion 222 
3.1. Occurrence of drug biomarkers in municipal wastewater of the city of Zagreb 223 
The analyses included selected drug biomarkers which are excreted after the consumption of 6 224 
illegal drugs (cannabis, heroin, cocaine, amphetamine, MDMA and methamphetamine) and 225 
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methadone which is primarily used in the treatment of heroin users. The analyses performed 226 
between 2009 and 2016 showed that most of the investigated drug biomarkers were rather 227 
common constituents in the wastewater of the city of Zagreb (Table 2).  The most frequently 228 
detected biomarkers were MOR, BE, THC-COOH and EDDP, which were determined in all 229 
analyzed wastewater samples (n = 270-282). Very high frequency of detection was obtained also 230 
for 6-AM (98%), M3G (97%), AMP (96%) and MDMA (99%; n = 282), whereas MAMP was the 231 
least frequently detected drug biomarker (83%). Regarding abundances, the highest average 232 
annual concentrations were determined for MOR (from 74 ± 29 ng/L to 294 ± 83 ng/L), BE (from 233 
143 ± 34 ng/L to 273 ± 101 ng/L) and EDDP (from 121 ± 41 ng/L to 190 ± 67 ng/L), followed by 234 
AMP (from 7.5 ± 7.5 ng/L to 109 ± 58 ng/L) and MDMA (from 6.8 ± 7.7 ng/L to 92 ± 58 ng/L). The 235 
lowest concentrations were determined for MAMP (from 0.6 ± 0.6 ng/L to 1.4 ± 1.8 ng/L), M3G 236 
(from 1.6 ± 2.2 ng/L to 9.9 ± 6.7 ng/L) and 6-AM (from 2.0 ± 2.4 ng/L to 12 ± 4.7 ng/L). 237 
 238 
3.2. Drug consumption patterns 239 
3.2.1. Workday/weekend drug consumption patterns 240 
Possible differences in workday to weekend consumption patterns of individual drugs have 241 
been evaluated based on the ratios of weekend and workday daily mass loads of selected drug 242 
biomarkers for individual years (Fig. 1). It was arbitrarily assumed that a ratio significantly 243 
different from 1.0 ± 0.2 was a confirmation of some specific weekday-related consumption 244 
pattern. It should be stressed that the ratio for MOR consumption was calculated from the 245 
corresponding mass loads of the total morphine (MORtot). The MORtot mass loads were obtained 246 
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by summing up the daily mass loads of MOR and M3G (taking into account the molar ratio to 247 
MOR of 1.62). 248 
Almost all ratios of the weekend and workday average daily mass load of stimulating drug 249 
biomarkers, BE (1.5 ± 0.3 to 1.7 ± 0.5), MDMA (2.3 ± 0.5 to 4.3 ± 3.6 ) and AMP (1.0 ± 1.0 to 2.2 250 
± 1.3), were significantly (t-test) different from 1.0 ± 0.2. By contrast, most of the ratios for 251 
MORtot (0.95 ± 0.4 to 1.1 ± 0.3), 6-AM (0.6 ± 0.8 to 1.2 ± 0.3), THC-COOH (0.9 ± 0.4 to 1.2 ± 0.4) 252 
and EDDP (0.9 ± 0.3 to 1.1 ± 0.3) indicated a rather uniform consumption of heroin, cannabis 253 
and methadone throughout the week. The observed weekend-related drug consumption 254 
patterns of stimulating drugs (MDMA, cocaine and AMP) documented in this study not only fully 255 
support the results obtained in a number of previous studies based on 7 consecutive days 256 
sampling scheme (e.g. Krizman et al., 2015; Ort et al., 2014a; Terzic et al., 2010; Thomas et al 257 
2012), but also confirm the robustness of the applied whole-year sampling scheme to 258 
demonstrate the importance of weekday-weekend dynamics at long-term time scales. 259 
 260 
3.2.2. The impact of holiday season on drug consumption patterns  261 
The results of research dealing with the impact of holiday season on drug consumption patterns 262 
are presented in Fig. 2, Fig. S1  and Fig. 3. In both periods, the 1st of January (New Year) was 263 
characterized by a significantly enhanced daily mass load of BE (224 g/day and 197 g/day), 264 
MDMA (62 g/day and 67 g/day) and AMP (42 g/day and 60 g/day), which confirmed an 265 
increased consumption of all major stimulating drugs in holiday seasons (Fig. 2). By contrast, the 266 
25th of December (Christmas) was associated with an enhanced excretion of BE (166 g/day and 267 
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130 g/day) whereas the Christmas consumption of most amphetamine-type drugs (AMP and 268 
MDMA) was not clearly elevated. These results probably reflect the life-style differences of 269 
cocaine and amphetamine-type drug consumers within the investigated population. In both 270 
holiday season periods, a steady increase of MOR excretion towards Christmas was also 271 
observed. However this increase was not associated with the concomitant increase of 6-AM and 272 
therefore cannot be unequivocaly related to the enhanced consumption of heroin. 273 
Furthermore, unlike for stimulating drugs,  holiday-related consumption patterns could not be 274 
established for the remaining investigated drugs, such as cannabis and EDDP (Fig. S1). The 275 
comparison of the average mass loads during the two holiday season periods with the average 276 
weekend and workday mass loads in the corresponding years (Fig. 3) confirmed a significantly 277 
higher consumption (p < 0.05) of stimulating drugs (BE, MDMA, AMP) during the weekend (n = 278 
19-24) and holiday season period (n = 14-15) as compared to workday periods (n = 19-22). The 279 
average mass loads of stimulating drugs during Christmas holiday season were 2 – 3.9-fold 280 
higher than during the average weekday and 1.2 – 1.9-fold higher than during the average 281 
weekend of the corresponding year. This is in a good agreement with previous studies which 282 
indicated the enhanced consumption of stimulating drugs during the holidays, festivals, tourist 283 
seasons etc. (e.g. Krizman et al., 2016; Lai et al., 2013a; Lai et al. 2013b, van Nuijs et al., 2009) 284 
and underlines the ability of the applied WBE approach to address the problem of relative 285 
contributions of special events to the overal drug consumption in a particular yearly period.  286 
 287 
3.2.3. The seasonal differences in drug consumption patterns 288 
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In this study, we compared the average daily mass loads determined in the city of Zagreb in 2 289 
different one-week periods, early spring and summer, in 2009 and 2013. The results of this 290 
comparison are presented in Fig. 4. In both investigated years, the average summer mass loads 291 
of most of the investigated drug biomarkers were lower than those determined in early spring 292 
(Fig. 4). However the observed differences were statisticaly significant (p < 0.05; Mann-Whitney 293 
test) only for drug biomarkers which exhibit lower intra-week variability (e.g. MORtot, THC-COOH 294 
and EDDP) whereas they were not significant for the biomarkers of stimulating drugs (BE, 295 
MDMA), probably due to the comparatively higher intra-week variability. The lower average 296 
daily mass loads determined in summer are most likely associated with a disbalanced outward 297 
and inward population migrations during the summer vacation season. Namely, the 298 
contribution of  tourists to the total city population is rather negligible throughout the year 299 
(<1%, data from Zagreb Tourist Board), whereas a significant percentage of residential 300 
population might be out of town during the peak of summer season. Unfortunately, this 301 
assumption cannot be confirmed since the official data related to the outward migrations of the 302 
city population were not available. Another possible factor which might have caused the 303 
observed differences in spring and summer mass loads is faster in-sewer drug biomarker 304 
degradation at higher temperatures (e.g. Devault et al., 2017). However, the model experiments 305 
which were performed with the wastewater from the city of Zagreb at 10oC and 20oC, indicated 306 
rather higher stability of all urinary biomarkers included in this research at the both 307 
temperature conditions (Senta et al., 2016.). Since the in-sewer wastewater residence time in 308 
Zagreb is relatively short (<5 h) and a typical wastewater temperature in March and July/August 309 
is 12oC and 20.5oC, respectively, it is not very likely that the observed seasonal mass load 310 
16 
 
diferences were primarily caused by faster in-sewer degradation in summer. Although the 311 
reasons for the observed seasonal differences of the average mass loads are not yet fully 312 
understood, they indicated that the total drug consumption might be underestimated if 313 
extrapolated from the average daily mass loads determined in summer. 314 
 315 
3.3. Impact of sampling scheme on the estimation of drug consumption in multiannual studies 316 
Most of the previously conducted multiannual WBE studies were based on relatively short one-317 
week sampling periods (e.g. Kankaanpää et al., 2016; Mastroianni et al., 2017, Ort et al., 2014a; 318 
Zuccato et al. 2016), which, due to the possible week-to-week variability of daily mass loads, 319 
may be associated with a potential error in tracking the drug consumption on an annual basis. In 320 
this study, a comparison was made between the representative average daily mass loads of 321 
selected drug biomarkers obtained by applying two different sampling schemes: one-week 322 
sampling scheme (March/April 2012 – 2016) and whole-year sampling scheme (Sundays and 323 
Tuesdays; sampled either fortnightly in 2012-2014 or monthly in 2015-2016). Based on the 324 
extended scheme of the whole-year sampling carried out in 2013 and 2014, which included 325 
fortnightly sampling (n = 48), it was shown that the reduction of the sample number to half 326 
(monthly sampling; n = 24) did not significantly affect the estimate of the mass loads (t-test; p < 327 
0.05).   328 
The representative daily mass loads of individual drug biomarkers determined by applying the 329 
one-week and the whole-year sampling scheme are presented in Fig. 5. Apart from some 330 
occasional exceptions, the application of the whole-year sampling scheme was, in principle,  331 
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associated with somewhat higher day-to-day variability of daily mass loads than the one-week 332 
sampling scheme, which is probably a result of higher intra-annual variability of drug 333 
consumption. The amphetamine-type drugs  (MAMP, AMP and MDMA) exhibited the strongest 334 
day-to-day variability within the both sampling schemes, which is most probably associated with 335 
a rather irregular consumption pattern of these drugs, characterized by enhanced weekend and 336 
holiday consumption rates. Furthermore, the one-week sampling scheme was occasionally 337 
associated with relatively high day-to-day variability of AMP and MDMA. The statistical analysis 338 
of the data exhibited a significant difference (p < 0.05) between the representative mass loads 339 
of AMP obtained by the two applied sampling schemes in all investigated years. By contrast, the 340 
differences for other investigated drug biomarkers were found to be significant (p < 0.05) only 341 
occasionally. Previous study by Ort at al. (2014b) has shown that the variability of drug 342 
consumption in smaller communities (<10 000 inhabitants) is extremely high, requiring very 343 
high sampling frequency to achieve the proper estimate of drug consumption. It was estimated 344 
that the average annual consumption calculated from 1-week sampling was subject to 345 
approximately 60% relative error. In contrast, our study suggests that intra-annual varibilities in 346 
larger cities can be significantly smaller allowing detection of relatively small changes (20%) of 347 
the drug consumption among different years. Nevertheless, although some previous studies, 348 
addressing the issue of multiannual changes, demonstrated the applicability of one-week 349 
sampling scheme (Mastroianni et al., 2017; Ort et al. 2014a, Zuccato et al., 2016), our data show 350 
that such a scheme is insufficiently reliable for the drugs exhibiting high day-to-day and intra-351 
annual variability, even in case of larger cities like the city of Zagreb. 352 
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3.4. Multiannual trends in drug consumption patterns and comparison with available 353 
epidemiological data  354 
The back-calculations of drug consumption were based on representative daily mass loads 355 
determined for all samples collected within each investigated year, with the exception of those 356 
collected during the Christmas-New Year holiday seasons. The consumption was calculated for 357 
heroin, cocaine, AMP, MDMA, cannabis (THC) and methadone (MTHD).  The results expressed in 358 
mg/day/1000 inhabitants of age 15-64 are presented in Fig. 6, whereas the results expressed in 359 
other units (e.g. mg/day/1000 inhabitants, doses/day/1000 inhabitants, g/day, kg/year, kg/year 360 
of street purity drug) are given in Supplementary Material (Table S2). The highest illicit drug 361 
consumption rate was determined for cannabis (from 7368 ± 2197 mg/day/1000 inhabitants 15-362 
64 years to 19544 ± 4624 mg/day/1000 inhabitants 15-64 years), followed by heroin (from 107 ± 363 
104 mg/day/1000 inhabitants 15-64 years to 712 ± 193 mg/day/1000 inhabitants 15-64 years), 364 
cocaine (from 249 ± 27 mg/day/1000 inhabitants 15-64 years to 699 ± 121 mg/day/1000 365 
inhabitants 15-64 years), MDMA (from 17 ± 7.5 mg/day/1000 inhabitants 15-64 years to 259 ± 366 
69 mg/day/1000 inhabitants 15-64 years) and AMP (from 13 ± 8.8 mg/day/1000 inhabitants 15-367 
64 years to 213 ± 61 mg/day/100 inhabitants 15-64 years). The estimated consumption rate of 368 
the therapeutic opioid methadone was in the range from 280 ± 26 mg/day/1000 inhabitants 15-369 
64 years to 393 ± 61 mg/day/1000 inhabitants 15-64 years.  In principle, the determined drug 370 
consumption patterns and rates were rather similar to those determined in some other 371 
Mediterranean countries, like Spain and Italy (Mastroianni et al., 2017; Zuccato et al., 2016), 372 
although some differences regarding the prevalence of individual drugs as well as regarding the 373 
temporal trends were observed. For example, cannabis and cocaine were the most prevalently 374 
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consumed illicit drugs in Barcelona (Spain) and investigated Italian cities, whereas a heroin 375 
consumption was reported to be much lower (Mastroianni et al., 2017; Zuccato et al., 2016).  376 
In our study, all investigated illicit drugs, except heroin, exhibited a significant increase (p < 377 
0.05) of the consumption rates over the investigated 8-year period (Fig. 6 and 7, Table S2). In 378 
2016, the average consumption rate of pure MDMA, AMP, THC (cannabis) and cocaine, were 379 
15-fold, 16-fold, 3-fold and 2-fold higher than in 2009, respectively. The multiannual 380 
consumption patterns of pure AMP and MDMA were characterized by a rather continuing 381 
increase of their consumption rates (Fig. 6) over the whole investigated time period, whereas 382 
the consumption of THC (cannabis) was characterized by a significant increase in 2009-2014 383 
period (p < 0.05, 3-fold increase), and rather stable consumption rate in 2014-2016 period. By 384 
contrast, the consumption rate of pure heroin dropped significantly (p < 0.05; 5-7-fold) between 385 
2009 and 2011-2012 period, and kept at significantly lower level until 2016 (p < 0.05). However, 386 
a significant (p < 0.05) 2-3-fold increase in pure heroin consumption was recorded between 387 
2011/2012 and 2016, which indicated a gradual recovery of heroin market in that period. 388 
Interestingly, a reduction of heroin consumption in the period 2010-2012 was reported for Italy 389 
as well (Zuccato et al., 2016). 390 
Based on the estimated amounts of consumed drugs and the official data on purity of seized 391 
drugs provided by the Office for Combating Narcotic Drug Abuse of the Government of the 392 
Republic of Croatia (see Table S1), we calculated the amounts of the street-purity drugs which 393 
circulated on the illegal market in Zagreb in the corresponding years (Table S2). It should be 394 
stressed that the street-drug purity of investigated drugs (heroin, amphetamine, MDMA, 395 
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cocaine) exhibited a pronounced temporal variability (Table S2). The amounts of the most 396 
prevalent drugs present on the illegal market in Zagreb were as follows: from 211 to 565 397 
kg/year of heroin, from 157 to 323 kg/year of cocaine, from 44 to 309 kg/year of amphetamine, 398 
from 14 to 127 kg/year of MDMA and from 22853 to 53988 kg/year of cannabis.   399 
Consequently, the observed multiannual trends in the consumption of pure drugs are probably 400 
not impacted exclusively by the changes in drug consumption prevalence but also by the 401 
changes in the street drug purity. In this context, it is interesting to note that a significant drop 402 
in the heroin consumption rate between 2009 and 2011/2012 was associated with a 403 
concomitant decrease of heroin street-drug purity (from 21.5% to 8.4%) and an increase in the 404 
consumption of the substitution therapy drug methadone (40%), which then kept a rather 405 
stable consumption rate in the subsequent period (2013-2016). The average number of 406 
consumed methadone doses estimated in this study (e.g. 3.1 ± 0.4 doses/day/1000 inhabitants 407 
in 2015; 80 mg/dose) were in a rather good agreement with the amount of that drug prescibed 408 
in the city of Zagreb in 2015 (11.76 DDD/TSD; DDD = 25 mg; 3.7 doses/day/1000 inhabitants for 409 
the average dose of 80 mg/L) (Draganic et al., 2017), which confirmed a reliability of WBE 410 
approach for tracking the changes of the illicit drug consumption patterns.  411 
The trends in population normalized number of addicts treated due to consumption of different 412 
types of drugs did not, however, reflect the multiannual drug consumption trends determined 413 
in this study (Fig. 7), probably due to a rather long time-gap between the initial drug 414 
consumption and the involvement of the consumers in the treatment.  415 
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Furthermore, the drug consumption trends which were determined in the present study were 416 
only partialy in agreement with the results of general population surveys performed in Croatia 417 
in 2011 and 2015, which indicated a significant increase only in the consumption of cannabis 418 
(2.9% last-month prevalence in 2011; 5.0% last-month prevalence in 2016) (Glavak Tkalic et al., 419 
2013; Glavak Tkalic et al., 2016), whereas the differences in the consumption prevalence of 420 
other illicit drugs were not found to be significant. Our study suggests that the outcome of 421 
national population surveys on drug consumption is not necessarily representative for larger 422 
cities. Given the fact that the city of Zagreb represents approximately 20% of the whole Croatian 423 
population, the drug consumption trends determined in this study imply the need for specific 424 
surveys focusing on larger cities. Moreover, the trends observed in the city of Zagreb might be 425 
an indication of some trends developing at the national level.   426 
 427 
5. Conclusion 428 
The eight-year monitoring period of drug consumption patterns in the city of Zagreb, Croatia, 429 
using wastewater-based epidemiology revealed several temporal variability patterns, including 430 
weekday-weekend dynamics, holiday season effects and multiannual trends. In agreement with 431 
the literature, the enhanced consumption of stimulating drugs was systematically observed 432 
during weekends and Christmas holiday season. In addition, a significant multiannual increase of 433 
cocaine (1.6-fold), THC (2.7-fold), amphetamine (16-fold) and MDMA (15-fold) consumption 434 
with a concomitant decrease (2.3-fold) of the consumption of heroin was observed during the 435 
investigated 8-year period (2009-2016). The whole-year sampling scheme showed a clear 436 
22 
 
advantage over the one-week sampling scheme, especially for drugs showing enhanced day-to-437 
day and intra-annual variability. The errors associated with day-to-day and intra-annual 438 
variability of BE (<20%) determined in the city of Zagreb (>500 000 inhabitants) study were 439 
much smaller from those reported for small communities (Ort et al. 2014b), which indicated 440 
enhanced robustness of the estimates obtained for large sized cities. Our data suggest that large 441 
sized cities can provide a basis for a reliable detection of relatively small changes in drug 442 
consumption over a multi-year period. Consequently, the trends observed in the larger cities 443 
could be used as an early warning of the trends developing at the national level.   444 
 445 
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Figure captions 618 
 619 
Fig. 1.  Ratios of weekend and workday average mass loads of selected urinary drug biomarkers 620 
(MORtot, 6-AM, AMP, MDMA, BE, THC-COOH, EDDP) determined in the period from 2009 to 621 
2016. Error bars represent standard deviations. Horizontal lines represent arbitrarily assumed  622 
weekend to workday mass load ratio of 1.0 ± 0.2. 623 
Fig. 2.  Mass loads of BE, MDMA and AMP in two different Christmas-New Year holiday periods: 624 
A) 2012/2013 and B) 2013/2014. 625 
Fig. 3.  Average mass loads of selected drug biomarkers determined on workdays, weekend and 626 
during two Christmas-New Year periods: A) 2012/2013 and B) 2013/2014. Error bars represent 627 
standard deviations. 628 
Fig. 4. Variability of average mass loads of selected urinary drug biomarkers in Zagreb during the 629 
spring and summer sampling week in A) 2009 and B) 2013. Error bars represent standard 630 
deviations. 631 
Fig. 5. Impact of the selected sampling schemes (whole-year and one-week monitoring) on the 632 
determination of representative mass loads. Error bars represent standard deviations. 633 
Fig. 6. Consumption of cocaine, heroin, MDMA, amphetamine, THC and methadone in the city 634 
of Zagreb in the period 2009-2016. Error bars represent standard deviations. 635 
33 
 
Fig. 7. Comparison of estimated drug consumption in the city of Zagreb with available 636 
epidemiological data for Croatia in the period of 2009-2016. Stimulants in the epidemiological 637 
figure include amphetamine-type drugs. Opiates include heroin and morphine.  638 
Table 1. Selected drug biomarkers and data used for estimation of drug consumption. 
 
Drug 
 
Biomarker for 
estimation of 
consumption 
Percentage of drug 
doses excreted as 
drug biomarker 
Molar 
ratio 
Correction 
factor 
Dose (mg) 
Heroin 6-AM 1.3 1.13 86.9
a
 10
d
 
Cocaine BE 29 1.05 3.6
b
 30
d
 
Amphetamine AMP 36 1.00 2.8
c
 10
c
 
MDMA MDMA 22.5 1.00 4.4
c
 97
d
 
THC (Cannabis) THC-COOH 0.5 0.91 182
c
 125
c
 
Methadone EDDP 25 1.12 3.6 80
e
 
a
van Nuijs et al., 2011; 
b
Castiglioni et al.,  2013; 
c
Gracia-Lor et al., 2016; 
d
Office for Combating Narcotic Drug Abuse of 
the Government of the Republic of Croatia, data for 2013; 
e
Croatian Institute of Public Health, data for Zagreb for 
2010. 
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Table 2. Mass loads of urinary biomarkers (MORtot, MOR, M3G, 6-AM, MAMP, AMP, MDMA, BE, 
MDMA, THC-COOH, EDDP) in raw wastewater of the city of Zagreb (Croatia) in the period 2009 - 2016. 
Urinary drug 
biomarker 
Year na FDb 
Concentration 
range  
(ng/L) 
Average ± SD 
(ng/L) 
Mass load 
range  
(g/day) 
Average ± SD 
(g/day) 
MORtot 
2009 39 100 161 - 476 294 ± 83 45 -106 75 ± 15 
2011 7 100 130 - 160 142 ± 10.8 30 - 36 32 ± 2.4 
2012 54 100 26 - 183 95 ± 37 11 - 61 27 ± 12 
2013 72 100 33 - 167 90 ± 32 17 - 50 28 ± 6.8 
2014 54 100 25 - 129 80 ± 28 17 - 62 28 ± 7.5 
2015 30 100 45 - 144 94 ± 23 16 - 39 30 ± 5.2 
2016 26 100 49 - 147 97 ± 22 18 - 44 35 ± 6.2 
MOR 
2009 39 100 160 - 476 294 ± 83 45 - 106 75 ± 15 
2011 7 100 109 - 135 120 ± 9.3 25 - 31 27 ± 2.1 
2012 54 100 19 - 183 94 ± 37 11 - 61 27 ± 12 
2013 72 100 26 - 166 86 ± 32 15 - 50 27 ± 7.0 
2014 54 100 22 - 127 74 ± 29 13 - 61 26 ± 7.3 
2015 30 100 41 - 141 91 ± 22 16 - 38 29 ± 5.0 
2016 26 100 42 - 143 91 ± 23 17 - 41 32 ± 5.7 
M3G 
2009 0 NA NA NA NA NA 
2011 7 100 3.3 - 5.5 4.7 ± 0.7 0.7 - 1.3 1.1 ± 0.2 
2012 54 85 < 0.2 – 10.5 1.6 ± 2.2 < 0.03 – 6.8 0.5 ± 1.1 
2013 72 100 < 0.3 - 19 6.6 ± 4.9 < 0.1 – 8.9 2.3 ± 2.0 
2014 54 100 < 0.3 -29 8.5 ± 6.7 < 0.1 -15 3.4 ± 3.3 
2015 30 100 < 0.3 - 16 3.9 ± 4.2 < 0.1 -6.5 1.2 ± 1.5 
2016 26 100 < 0.3 -24 9.9 ± 6.7 < 0.1 -11 3.9 ± 3.0 
6-AM 
2009 39 100 3.3 - 28 12 ± 4.7 0.7 - 6.0 3.1 ± 1.2 
2011 7 100 2.3 – 4.2 3.3 ± 0.6 0.5 - 0.96 0.8 ± 0.1 
2012 54 91 < 0.1 - 16 2.0 ± 2.4 < 0.01 - 3.7 0.5 ± 0.6 
2013 72 100  0.1 – 14 3.1 ± 1.9  0.1 - 3 1.1 ± 0.5 
2014 54 100  0.1 – 7.0 3.1 ± 1.04 0.1 - 2.3 1.2 ± 0.4 
2015 30 93 < 0.1 – 7.6 3.4 ± 1.8 < 0.04 - 1.9 1.1 ± 0.5 
2016 26 100 2.2 - 16 5.0 ± 2.9 0.7 - 4.1 1.7 ± 0.7 
 MAMP 
2009 0 NA NA NA NA NA 
2011 0 NA NA NA NA NA 
2012 54 83 < 0.2 – 4.0 0.7 ± 0.9 < 0.1 - 0.96 0.2 ± 0.2 
2013 72 78 < 0.2 – 3.8 1.1± 1.0 < 0.1 - 2 0.4 ± 0.5 
2014 54 78 < 0.2 – 2.8 0.63 ± 0.66 < 0.1 - 1.9 0.25 ± 0.3 
2015 30 100 < 0.4 – 5.9 1.4 ± 1.8 < 0.1 - 1.7 0.4 ± 0.5 
2016 26 89 < 0.2 - 12 1.3 ± 2.3 < 0.1 – 3.7 0.5 ± 0.7 
AMP 
2009 39 72 < 1.3 - 35 7.5 ± 7.5 < 0.3 - 7.6 1.9 ± 1.8 
2011 7 100 32 - 62 42 ± 10.3 7.2 -13 9.5 ± 2.1 
2012 54 100 7.2 - 58 27 ± 15 2.3 - 17 7.5 ± 4.1 
2013 72 100 6.3 - 235 45 ± 38 2.7 - 63 13 ± 8.4 
2014 54 100 14 - 149 51 ± 26 6.1 - 74 18 ± 12 
2015 30 100 34 - 320 100 ± 70 12 -111 32 ± 23 
2016 26 100 25 - 295 109 ± 58 15 - 89 38 ± 19 
MDMA 
2009 39 79 < 1.1 - 33 6.8 ± 7.7 < 0.2 - 7.4 1.7 ± 1.7 
2011 7 100 5.3 - 16 9.4 ± 4.6 1.2 - 3.6 2.1 ± 1.0 
2012 54 98 < 0.1 - 96 26 ± 22 < 0.03 - 21 7.1 ± 4.9 
2013 72 100 3.4 - 260 30 ± 40 1.8 - 62 8.5 ± 8.7 
Table 2
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2014 54 100 8.0 - 133 38 ± 30 3.4 - 67 15 ± 12 
2015 30 100 23 - 316 91 ± 68 7.6 - 92 28 ± 19 
2016 26 100 18 - 215 92 ± 58 8.9 - 80 32 ± 20 
BE 
2009 39 100 89 - 325 186 ± 59 27 - 77 47 ± 12 
2011 7 100 100 - 189 143 ± 34 22 - 43 32 ± 7.6 
2012 54 100 52 - 497 196 ± 94 24 -166 56 ± 29 
2013 72 100 57 - 769 203 ± 125 31 - 224 60 ± 27 
2014 54 100 35 - 399 150 ± 66 24 - 197 57 ± 29 
2015 30 100 114 - 474 236 ± 96 45 - 125 75 ± 24 
2016 26 100 92 - 520 273 ± 101 52 - 173 97 ± 32 
THC-COOH 
2009 30 100 21 - 128 60 ± 23 7.3 - 31 16 ± 5.5 
2011 7 100 71 - 100 87 ± 10.4 16 -22 20 ± 2.2 
2012 54 100 34 - 183 107 ± 36 18 -52  30 ± 7.4 
2013 72 100 44 - 214 133 ± 43 16 - 74 42 ± 11 
2014 54 100 38 - 312 137 ± 54 19 - 117 49 ± 16 
2015 30 100 52 - 309 141 ± 58 15 - 88 45 ± 17 
2016 24 100 60 - 363 156 ± 66 32 - 105  54 ± 14 
EDDP 
2009 27 100 71 - 156 128 ± 20 24 - 38 30 ± 3.6 
2011 7 100 177 - 196 184 ± 6.5 40 - 45 42 ± 1.8 
2012 54 100 61 - 330 190 ± 67 25 - 69 52 ± 10.4 
2013 72 100 60 - 220 140 ± 43 31 - 67 43 ± 7.9 
2014 54 100 44 - 220 121 ± 41 29 - 92 43 ± 11 
2015 30 100 85 - 205 145 ± 24 25 - 67 47 ± 8.9 
2016 26 100 67 - 194 128 ± 34 26 - 60 45 ± 7.2 
aNumber of analyzed samples; bFrequency of detection; NA – not applicable 
  
 
 
Figure 1. Ratios of weekend and workday average mass loads of selected urinary drug biomarkers 
(MORtot, 6-AM, AMP, MDMA, BE, THC-COOH, EDDP) determined in the period from 2009 to 2016. Error 
bars represent standard deviations. Horizontal lines represent arbitrarily assumed  weekend to workday 
mass load ratio of 1.0 ± 0.2. 
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A) 
 
B) 
 
Fig. 2.  Mass loads of BE, MDMA and AMP in two different Christmas-New Year holiday periods: 
A) 2012/2013 and B) 2013/2014. 
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(A) 
 
 
(B) 
 
Fig. 3. Average mass loads of selected drug biomarkers determined on workdays, weekend and during 
two Christmas-New Year periods: A) 2012/2013 and B) 2013/2014. Error bars represent standard 
deviations. 
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Fig. 4. Variability of average mass loads of selected urinary drug biomarkers in Zagreb during the 
spring and summer sampling week in A) 2009 and B) 2013. Error bars represent standard deviations. 
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Figure 5. Impact of the selected sampling strategy (whole-year and one-week monitoring) on the determination of 
representative mass loads. 
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Fig. 6. Consumption of cocaine, heroin, MDMA, amphetamine, THC and methadone in the city of Zagreb in the period 2009-2016. Error bars represent 
standard deviations. 
 
Figure 6
Click here to download Figure: Fig 6_R1.doc
0.0
0.5
1.0
1.5
2.0
2.5
OPIATES COCAINE STIMULANTS CANNABIS
Tr
ea
te
d
 p
at
ie
n
ts
/d
ay
/1
00
0 
in
h
. (
15
-6
4
 
y
e
ar
)
2009
2010
2011
2012
2013
2014
2015
2016
71
14
1.
3
0.
2
59
14
8.
3
5.
7
0.
2
62
11 10
3.
5
0.
5
91
21
13
5.
5
0.
6
12
5
22
13 10
1.
1
15
4
20 17 17
2.
3
14
4
32
23 21
2.
7
15
6
0
20
40
60
80
100
120
140
160
180
HEROIN COCAINE AMPHETAMINE MDMA CANNABIS
D
o
se
s/
d
ay
/1
00
0 
in
h
. (
15
-6
4 
ye
ar
)
2009
2011
2012
2013
2014
2015
2016
 
Fig. 7. Comparison of estimated drug consumption in the city of Zagreb with available epidemiological 
data for Croatia in the period of 2009-2016. Stimulants in the epidemiological figure include 
amphetamine-type drugs. Opiates include heroin and morphine. 
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